Gene Symbol | Gene ID | Gene Info |
---|---|---|
Nfe2
|
ENSMUSG00000058794.6 | nuclear factor, erythroid derived 2 |
Bach1
|
ENSMUSG00000025612.5 | BTB and CNC homology 1, basic leucine zipper transcription factor 1 |
Mafk
|
ENSMUSG00000018143.4 | v-maf musculoaponeurotic fibrosarcoma oncogene family, protein K (avian) |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr16_87713119_87713319 | Bach1 | 14215 | 0.203699 | 0.92 | 6.5e-24 | Click! |
chr16_87713410_87713580 | Bach1 | 14491 | 0.202987 | 0.91 | 4.3e-22 | Click! |
chr16_87705974_87706150 | Bach1 | 7058 | 0.226667 | 0.91 | 7.8e-22 | Click! |
chr16_87706303_87706716 | Bach1 | 7505 | 0.224442 | 0.88 | 6.3e-19 | Click! |
chr16_87712831_87713000 | Bach1 | 13911 | 0.204485 | 0.87 | 3.6e-18 | Click! |
chr5_139794903_139795230 | Mafk | 2448 | 0.184508 | 0.83 | 5.6e-15 | Click! |
chr5_139792232_139792395 | Mafk | 779 | 0.513697 | 0.74 | 7.4e-11 | Click! |
chr5_139793074_139793252 | Mafk | 1629 | 0.257957 | 0.70 | 2.5e-09 | Click! |
chr5_139792850_139793006 | Mafk | 1394 | 0.298939 | 0.68 | 1.2e-08 | Click! |
chr5_139790880_139791640 | Mafk | 253 | 0.872981 | 0.66 | 3.4e-08 | Click! |
chr15_103251687_103251873 | Nfe2 | 93 | 0.939899 | 0.95 | 2.5e-28 | Click! |
chr15_103252000_103252244 | Nfe2 | 435 | 0.705136 | 0.93 | 2.0e-25 | Click! |
chr15_103252776_103252951 | Nfe2 | 53 | 0.950450 | 0.92 | 3.5e-23 | Click! |
chr15_103254729_103254965 | Nfe2 | 592 | 0.582612 | 0.90 | 5.6e-21 | Click! |
chr15_103255163_103255602 | Nfe2 | 57 | 0.949358 | 0.89 | 3.8e-20 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr7_103860925_103861255 | 141.88 |
Hbb-y |
hemoglobin Y, beta-like embryonic chain |
7874 |
0.06 |
chr2_8628513_8628745 | 125.76 |
Gm13255 |
predicted gene 13255 |
5308 |
0.36 |
chr4_14898779_14899118 | 124.22 |
Gm11837 |
predicted gene 11837 |
30960 |
0.17 |
chr13_81852671_81852937 | 121.16 |
Cetn3 |
centrin 3 |
60827 |
0.11 |
chr9_42461386_42461564 | 119.57 |
Tbcel |
tubulin folding cofactor E-like |
14 |
0.98 |
chr9_60653167_60653455 | 117.62 |
Lrrc49 |
leucine rich repeat containing 49 |
3510 |
0.26 |
chr5_149623894_149624082 | 117.23 |
Hsph1 |
heat shock 105kDa/110kDa protein 1 |
2801 |
0.21 |
chr6_38316078_38316363 | 116.55 |
Zc3hav1l |
zinc finger CCCH-type, antiviral 1-like |
16961 |
0.13 |
chr9_99256898_99257049 | 116.31 |
Gm47199 |
predicted gene, 47199 |
3234 |
0.13 |
chr5_137103007_137103296 | 115.78 |
Trim56 |
tripartite motif-containing 56 |
13056 |
0.11 |
chr5_124052205_124052548 | 110.99 |
Gm43661 |
predicted gene 43661 |
24 |
0.95 |
chr16_11270757_11270983 | 109.10 |
Mir1945 |
microRNA 1945 |
16425 |
0.12 |
chr1_184657439_184657611 | 108.00 |
Gm37800 |
predicted gene, 37800 |
28052 |
0.12 |
chr16_8810865_8811172 | 104.26 |
Usp7 |
ubiquitin specific peptidase 7 |
18710 |
0.15 |
chr14_103087028_103087190 | 101.79 |
Fbxl3 |
F-box and leucine-rich repeat protein 3 |
2708 |
0.21 |
chr4_33467249_33467421 | 98.76 |
Gm11935 |
predicted gene 11935 |
14446 |
0.21 |
chr16_94235829_94236007 | 98.70 |
Gm6363 |
predicted gene 6363 |
7429 |
0.14 |
chr8_47510988_47511249 | 97.25 |
Trappc11 |
trafficking protein particle complex 11 |
230 |
0.92 |
chr4_149632790_149632942 | 96.72 |
Clstn1 |
calsyntenin 1 |
5736 |
0.15 |
chr7_135813684_135813871 | 96.01 |
6330420H09Rik |
RIKEN cDNA 6330420H09 gene |
39905 |
0.12 |
chr2_173038101_173038586 | 89.00 |
Gm14453 |
predicted gene 14453 |
3763 |
0.17 |
chr19_21568912_21569068 | 88.22 |
Gm3443 |
predicted gene 3443 |
16049 |
0.21 |
chr2_125901161_125901325 | 87.66 |
Galk2 |
galactokinase 2 |
34975 |
0.17 |
chr11_79071590_79071929 | 86.52 |
Ksr1 |
kinase suppressor of ras 1 |
2727 |
0.3 |
chr15_81891900_81892067 | 85.97 |
Aco2 |
aconitase 2, mitochondrial |
3323 |
0.12 |
chr17_10042362_10042539 | 85.88 |
Gm49809 |
predicted gene, 49809 |
94613 |
0.08 |
chr1_161301455_161301634 | 85.42 |
Gm19057 |
predicted gene, 19057 |
2530 |
0.29 |
chr7_103865767_103866083 | 85.41 |
Hbb-y |
hemoglobin Y, beta-like embryonic chain |
12709 |
0.06 |
chrX_164269205_164269889 | 83.09 |
Pir |
pirin |
0 |
0.96 |
chr13_94262666_94262857 | 83.08 |
Scamp1 |
secretory carrier membrane protein 1 |
2385 |
0.25 |
chr11_116142703_116142877 | 82.30 |
Mrpl38 |
mitochondrial ribosomal protein L38 |
3922 |
0.11 |
chr1_70918346_70918644 | 81.44 |
Gm16236 |
predicted gene 16236 |
121535 |
0.06 |
chr18_6760941_6761115 | 80.91 |
Gm7466 |
predicted gene 7466 |
69 |
0.97 |
chr17_24617967_24618127 | 79.36 |
Tsc2 |
TSC complex subunit 2 |
3466 |
0.1 |
chr18_70563552_70563708 | 79.15 |
Mbd2 |
methyl-CpG binding domain protein 2 |
4559 |
0.21 |
chr19_58978781_58978960 | 78.03 |
Eno4 |
enolase 4 |
23414 |
0.16 |
chr2_73023761_73024098 | 77.46 |
Sp3os |
trans-acting transcription factor 3, opposite strand |
36688 |
0.12 |
chr8_94151077_94151253 | 76.84 |
Mt3 |
metallothionein 3 |
1442 |
0.26 |
chr9_95546807_95546963 | 76.78 |
Gm32281 |
predicted gene, 32281 |
7612 |
0.14 |
chr5_36620785_36620943 | 76.26 |
D5Ertd579e |
DNA segment, Chr 5, ERATO Doi 579, expressed |
391 |
0.77 |
chr12_58981232_58981506 | 76.25 |
Sec23a |
SEC23 homolog A, COPII coat complex component |
1335 |
0.35 |
chr1_87648753_87648925 | 75.79 |
Inpp5d |
inositol polyphosphate-5-phosphatase D |
27165 |
0.14 |
chr17_84926246_84926536 | 75.74 |
Gm49982 |
predicted gene, 49982 |
23822 |
0.14 |
chr4_62431601_62431846 | 75.40 |
Rnf183 |
ring finger protein 183 |
3003 |
0.16 |
chr3_79995785_79996245 | 75.16 |
A330069K06Rik |
RIKEN cDNA A330069K06 gene |
58877 |
0.11 |
chr1_189757143_189757301 | 74.76 |
Ptpn14 |
protein tyrosine phosphatase, non-receptor type 14 |
28947 |
0.16 |
chr11_116573227_116573521 | 73.92 |
Ube2o |
ubiquitin-conjugating enzyme E2O |
8073 |
0.1 |
chr17_72839097_72839276 | 73.50 |
Ypel5 |
yippee like 5 |
815 |
0.73 |
chr7_142393276_142393477 | 72.78 |
Ctsd |
cathepsin D |
5338 |
0.11 |
chr19_9978492_9978658 | 72.64 |
Fth1 |
ferritin heavy polypeptide 1 |
2023 |
0.18 |
chr11_116571940_116572280 | 71.65 |
Ube2o |
ubiquitin-conjugating enzyme E2O |
9337 |
0.1 |
chr1_130741324_130741621 | 71.13 |
Gm28857 |
predicted gene 28857 |
145 |
0.89 |
chr11_60935403_60935625 | 70.72 |
Map2k3 |
mitogen-activated protein kinase kinase 3 |
3448 |
0.16 |
chr1_174172656_174172830 | 70.65 |
Spta1 |
spectrin alpha, erythrocytic 1 |
33 |
0.95 |
chr12_3285550_3285711 | 67.96 |
Rab10 |
RAB10, member RAS oncogene family |
24339 |
0.14 |
chrX_12312513_12312900 | 67.60 |
Gm14635 |
predicted gene 14635 |
32516 |
0.21 |
chr9_66894964_66895296 | 66.59 |
Rab8b |
RAB8B, member RAS oncogene family |
24557 |
0.13 |
chr6_112684189_112684354 | 66.56 |
Rad18 |
RAD18 E3 ubiquitin protein ligase |
8495 |
0.22 |
chr14_122691599_122691889 | 66.22 |
Gm49260 |
predicted gene, 49260 |
5428 |
0.23 |
chr11_107986063_107986254 | 65.72 |
Prkca |
protein kinase C, alpha |
6519 |
0.16 |
chr10_115236816_115236977 | 65.71 |
Tbc1d15 |
TBC1 domain family, member 15 |
14357 |
0.17 |
chr14_118750627_118750802 | 65.55 |
Gm27198 |
predicted gene 27198 |
15569 |
0.15 |
chr7_75587851_75588026 | 64.89 |
Akap13 |
A kinase (PRKA) anchor protein 13 |
22101 |
0.17 |
chr9_109009726_109009899 | 64.76 |
Pfkfb4 |
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 |
1374 |
0.24 |
chr5_22485784_22486081 | 64.55 |
Gm43110 |
predicted gene 43110 |
12940 |
0.13 |
chr8_94109422_94109715 | 64.20 |
Bbs2 |
Bardet-Biedl syndrome 2 (human) |
10640 |
0.12 |
chr2_84059340_84059550 | 63.88 |
Gm13692 |
predicted gene 13692 |
24832 |
0.14 |
chr17_84922055_84922228 | 63.85 |
Gm49982 |
predicted gene, 49982 |
19572 |
0.15 |
chr5_129000807_129001084 | 63.74 |
Stx2 |
syntaxin 2 |
1310 |
0.46 |
chr2_62619174_62619348 | 63.40 |
Ifih1 |
interferon induced with helicase C domain 1 |
20212 |
0.17 |
chr15_73434906_73435096 | 62.90 |
Gm10362 |
predicted gene 10362 |
6091 |
0.15 |
chr17_79350758_79351146 | 62.78 |
Cdc42ep3 |
CDC42 effector protein (Rho GTPase binding) 3 |
2055 |
0.34 |
chr9_52175573_52175754 | 62.72 |
Zc3h12c |
zinc finger CCCH type containing 12C |
7091 |
0.23 |
chr18_3270627_3271079 | 62.27 |
Crem |
cAMP responsive element modulator |
10225 |
0.22 |
chr11_57812276_57812671 | 61.56 |
Sap30l |
SAP30-like |
10836 |
0.14 |
chr9_22322453_22322618 | 61.37 |
Gm10182 |
predicted pseudogene 10182 |
1158 |
0.29 |
chr1_75179330_75179529 | 61.18 |
Abcb6 |
ATP-binding cassette, sub-family B (MDR/TAP), member 6 |
480 |
0.55 |
chr15_83565552_83565737 | 60.95 |
Tspo |
translocator protein |
1769 |
0.21 |
chr6_145276262_145276713 | 60.78 |
Rps25-ps1 |
ribosomal protein S25, pseudogene 1 |
10087 |
0.1 |
chr8_60859605_60859923 | 60.61 |
Gm45485 |
predicted gene 45485 |
13452 |
0.16 |
chr6_8345549_8345726 | 60.01 |
Gm16055 |
predicted gene 16055 |
18499 |
0.17 |
chr19_36451049_36451311 | 60.00 |
F530104D19Rik |
RIKEN cDNA F530104D19 gene |
23 |
0.98 |
chr1_130731479_130731652 | 58.92 |
AA986860 |
expressed sequence AA986860 |
411 |
0.67 |
chr15_6059706_6060114 | 58.46 |
Gm8047 |
predicted gene 8047 |
24949 |
0.22 |
chr6_57745472_57745766 | 58.32 |
Lancl2 |
LanC (bacterial lantibiotic synthetase component C)-like 2 |
42532 |
0.09 |
chr2_44969394_44969572 | 57.73 |
Gtdc1 |
glycosyltransferase-like domain containing 1 |
41826 |
0.15 |
chr16_21359520_21359922 | 57.71 |
Magef1 |
melanoma antigen family F, 1 |
26365 |
0.17 |
chr1_191880325_191880492 | 57.58 |
1700034H15Rik |
RIKEN cDNA 1700034H15 gene |
18721 |
0.13 |
chr6_67186949_67187125 | 57.55 |
Gm8566 |
predicted pseudogene 8566 |
18582 |
0.12 |
chr1_88109131_88109476 | 57.41 |
Ugt1a6b |
UDP glucuronosyltransferase 1 family, polypeptide A6B |
2441 |
0.1 |
chr3_51670694_51670977 | 57.34 |
Mgst2 |
microsomal glutathione S-transferase 2 |
628 |
0.59 |
chr7_90042519_90042690 | 57.24 |
Gm44861 |
predicted gene 44861 |
93 |
0.95 |
chr6_116286832_116287192 | 57.21 |
Zfand4 |
zinc finger, AN1-type domain 4 |
459 |
0.75 |
chr9_32559988_32560144 | 57.11 |
Fli1 |
Friend leukemia integration 1 |
17205 |
0.12 |
chr19_10173573_10173745 | 57.10 |
Gm50359 |
predicted gene, 50359 |
2502 |
0.16 |
chr9_70733299_70733478 | 57.09 |
Adam10 |
a disintegrin and metallopeptidase domain 10 |
42665 |
0.13 |
chr16_4200017_4200186 | 56.86 |
Crebbp |
CREB binding protein |
13312 |
0.16 |
chr17_33899741_33899912 | 56.83 |
Smim40 |
small integral membrane protein 40 |
5309 |
0.05 |
chr6_34157215_34157595 | 56.73 |
Gm13856 |
predicted gene 13856 |
5476 |
0.19 |
chr15_58927662_58927986 | 56.73 |
Tatdn1 |
TatD DNase domain containing 1 |
5544 |
0.14 |
chr5_135951162_135951333 | 56.05 |
Ssc4d |
scavenger receptor cysteine rich family, 4 domains |
11024 |
0.11 |
chr11_113681017_113681308 | 55.67 |
Gm11693 |
predicted gene 11693 |
2632 |
0.16 |
chr8_94169681_94169849 | 55.63 |
Mt2 |
metallothionein 2 |
2899 |
0.13 |
chr16_87713119_87713319 | 55.20 |
Bach1 |
BTB and CNC homology 1, basic leucine zipper transcription factor 1 |
14215 |
0.2 |
chr13_46725257_46725570 | 55.19 |
Nup153 |
nucleoporin 153 |
2527 |
0.25 |
chr1_191055236_191055510 | 55.10 |
Tatdn3 |
TatD DNase domain containing 3 |
3473 |
0.12 |
chr13_33003853_33004013 | 54.71 |
Serpinb9 |
serine (or cysteine) peptidase inhibitor, clade B, member 9 |
608 |
0.63 |
chr7_73517501_73517677 | 54.67 |
C130083A15Rik |
RIKEN cDNA C130083A15 gene |
11136 |
0.11 |
chr11_20916554_20916845 | 54.63 |
Gm23681 |
predicted gene, 23681 |
21002 |
0.18 |
chr2_136920981_136921193 | 54.57 |
Slx4ip |
SLX4 interacting protein |
15544 |
0.17 |
chr7_49762790_49762967 | 54.38 |
Htatip2 |
HIV-1 Tat interactive protein 2 |
3725 |
0.25 |
chr8_105801508_105801807 | 54.19 |
Ranbp10 |
RAN binding protein 10 |
25548 |
0.08 |
chr10_98880154_98880483 | 54.19 |
Atp2b1 |
ATPase, Ca++ transporting, plasma membrane 1 |
34088 |
0.21 |
chr2_103480341_103480729 | 53.99 |
Cat |
catalase |
4590 |
0.21 |
chr18_62169193_62169548 | 53.85 |
Adrb2 |
adrenergic receptor, beta 2 |
10589 |
0.19 |
chr5_92127193_92127372 | 53.56 |
Gm24931 |
predicted gene, 24931 |
8999 |
0.12 |
chr15_97361098_97361258 | 53.30 |
Pced1b |
PC-esterase domain containing 1B |
24 |
0.98 |
chr4_150523342_150523643 | 53.10 |
Rere |
arginine glutamic acid dipeptide (RE) repeats |
35099 |
0.17 |
chr13_58475506_58475838 | 52.97 |
Gm47918 |
predicted gene, 47918 |
32651 |
0.13 |
chr17_48447816_48447985 | 52.90 |
Tspo2 |
translocator protein 2 |
2170 |
0.2 |
chr11_82845821_82846014 | 52.79 |
Rffl |
ring finger and FYVE like domain containing protein |
175 |
0.91 |
chr12_87275169_87275339 | 52.62 |
Ahsa1 |
AHA1, activator of heat shock protein ATPase 1 |
5952 |
0.11 |
chr6_146454939_146455090 | 52.50 |
Gm15720 |
predicted gene 15720 |
8593 |
0.21 |
chr5_107470716_107470995 | 52.36 |
Gm9727 |
predicted gene 9727 |
8225 |
0.12 |
chr7_79271113_79271304 | 52.06 |
Gm31510 |
predicted gene, 31510 |
1603 |
0.26 |
chr8_83600902_83601120 | 52.05 |
Gm18001 |
predicted gene, 18001 |
998 |
0.34 |
chr14_74972805_74972992 | 51.98 |
Gm4278 |
predicted gene 4278 |
2188 |
0.3 |
chr3_133623505_133623696 | 51.84 |
Gm37228 |
predicted gene, 37228 |
11158 |
0.17 |
chr6_146230087_146230250 | 51.77 |
Itpr2 |
inositol 1,4,5-triphosphate receptor 2 |
2311 |
0.36 |
chr1_194985493_194985656 | 51.74 |
Gm37334 |
predicted gene, 37334 |
7684 |
0.1 |
chr4_130173547_130173713 | 51.71 |
Tinagl1 |
tubulointerstitial nephritis antigen-like 1 |
1061 |
0.47 |
chr9_52103611_52103784 | 51.54 |
Gm27686 |
predicted gene, 27686 |
82 |
0.97 |
chr1_43942923_43943075 | 51.28 |
Tpp2 |
tripeptidyl peptidase II |
8954 |
0.14 |
chr9_107312801_107313233 | 50.99 |
Gm17041 |
predicted gene 17041 |
11179 |
0.09 |
chr13_19178438_19178649 | 50.69 |
Gm31887 |
predicted gene, 31887 |
15015 |
0.21 |
chr11_57707443_57707667 | 50.66 |
Gm24582 |
predicted gene, 24582 |
33745 |
0.12 |
chr17_48264780_48264962 | 50.55 |
Treml4 |
triggering receptor expressed on myeloid cells-like 4 |
498 |
0.69 |
chr11_85103866_85104024 | 50.29 |
Rpl13-ps1 |
ribosomal protein L13, pseudogene 1 |
7848 |
0.14 |
chr11_95800592_95800866 | 49.98 |
Phospho1 |
phosphatase, orphan 1 |
23770 |
0.1 |
chr3_108096355_108096541 | 49.81 |
Gnat2 |
guanine nucleotide binding protein, alpha transducing 2 |
795 |
0.42 |
chr10_41214211_41214382 | 49.53 |
Gm25526 |
predicted gene, 25526 |
1749 |
0.38 |
chr4_33338112_33338316 | 49.35 |
Rngtt |
RNA guanylyltransferase and 5'-phosphatase |
7200 |
0.2 |
chr9_24280626_24280806 | 49.29 |
Npsr1 |
neuropeptide S receptor 1 |
2717 |
0.24 |
chr10_77225492_77225667 | 49.20 |
Pofut2 |
protein O-fucosyltransferase 2 |
33639 |
0.14 |
chr2_172256990_172257318 | 49.03 |
Mc3r |
melanocortin 3 receptor |
8662 |
0.18 |
chr6_38900298_38900449 | 49.01 |
Tbxas1 |
thromboxane A synthase 1, platelet |
18607 |
0.18 |
chr11_32250921_32251298 | 48.80 |
Nprl3 |
nitrogen permease regulator-like 3 |
831 |
0.45 |
chr11_10729247_10729415 | 48.80 |
Gm11997 |
predicted gene 11997 |
352249 |
0.01 |
chr7_120865910_120866142 | 48.78 |
Gm15774 |
predicted gene 15774 |
9272 |
0.13 |
chr3_127930366_127930648 | 48.74 |
9830132P13Rik |
RIKEN cDNA 9830132P13 gene |
14335 |
0.14 |
chr15_97786487_97787207 | 48.72 |
Slc48a1 |
solute carrier family 48 (heme transporter), member 1 |
2358 |
0.2 |
chr4_139334727_139334899 | 48.54 |
AL807811.1 |
aldo-keto reductase family 7 member A2 (AKR7A2) pseudogene |
2367 |
0.12 |
chr1_88140573_88140785 | 48.47 |
Ugt1a6a |
UDP glucuronosyltransferase 1 family, polypeptide A6A |
2301 |
0.1 |
chr8_107403479_107403664 | 48.15 |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
365 |
0.83 |
chr14_34190450_34190717 | 48.10 |
Gprin2 |
G protein regulated inducer of neurite outgrowth 2 |
11050 |
0.08 |
chr11_102375874_102376188 | 47.77 |
Bloodlinc |
Bloodlinc, erythroid developmental long intergenic non-protein coding transcript |
989 |
0.36 |
chr13_96697933_96698100 | 47.66 |
Gm48575 |
predicted gene, 48575 |
19893 |
0.14 |
chr6_87867373_87867524 | 47.40 |
Gm44064 |
predicted gene, 44064 |
16239 |
0.08 |
chr5_75460066_75460282 | 47.26 |
Gm42800 |
predicted gene 42800 |
60802 |
0.11 |
chr12_110953589_110953752 | 47.13 |
Ankrd9 |
ankyrin repeat domain 9 |
24585 |
0.1 |
chr8_13208726_13208929 | 47.12 |
2810030D12Rik |
RIKEN cDNA 2810030D12 gene |
8007 |
0.1 |
chr17_25127091_25127504 | 47.04 |
Clcn7 |
chloride channel, voltage-sensitive 7 |
6094 |
0.1 |
chr5_36735226_36735418 | 46.70 |
Gm43701 |
predicted gene 43701 |
13296 |
0.12 |
chr11_29645547_29645765 | 46.62 |
Gm12092 |
predicted gene 12092 |
147 |
0.94 |
chr19_5966902_5967059 | 46.10 |
Pola2 |
polymerase (DNA directed), alpha 2 |
2778 |
0.11 |
chr13_34348588_34348898 | 46.04 |
Slc22a23 |
solute carrier family 22, member 23 |
3561 |
0.23 |
chr4_108990164_108990336 | 45.50 |
Gm23589 |
predicted gene, 23589 |
8456 |
0.13 |
chr16_8746583_8746871 | 45.40 |
Usp7 |
ubiquitin specific peptidase 7 |
8307 |
0.16 |
chr4_145222134_145222422 | 45.34 |
Tnfrsf1b |
tumor necrosis factor receptor superfamily, member 1b |
24592 |
0.17 |
chr19_6102561_6102728 | 45.22 |
Naaladl1 |
N-acetylated alpha-linked acidic dipeptidase-like 1 |
3138 |
0.07 |
chr16_87699798_87700277 | 45.10 |
Bach1 |
BTB and CNC homology 1, basic leucine zipper transcription factor 1 |
1033 |
0.58 |
chr7_110941721_110941915 | 44.94 |
Mrvi1 |
MRV integration site 1 |
4369 |
0.22 |
chr15_95883474_95883993 | 44.93 |
Gm25070 |
predicted gene, 25070 |
3916 |
0.23 |
chr7_49764081_49764300 | 44.76 |
Htatip2 |
HIV-1 Tat interactive protein 2 |
5037 |
0.23 |
chr17_71171171_71171368 | 44.67 |
Lpin2 |
lipin 2 |
11291 |
0.15 |
chr1_13259586_13259781 | 44.65 |
Gm27881 |
predicted gene, 27881 |
2515 |
0.21 |
chr1_45873366_45873529 | 44.64 |
Gm5526 |
predicted pseudogene 5526 |
15693 |
0.12 |
chr3_146376932_146377125 | 44.63 |
Gm10636 |
predicted gene 10636 |
1916 |
0.25 |
chr15_9086931_9087289 | 44.55 |
Nadk2 |
NAD kinase 2, mitochondrial |
1310 |
0.49 |
chr4_115103597_115103762 | 44.54 |
Pdzk1ip1 |
PDZK1 interacting protein 1 |
12747 |
0.13 |
chr10_111583953_111584136 | 44.53 |
4933440J02Rik |
RIKEN cDNA 4933440J02 gene |
10229 |
0.16 |
chr11_4543069_4543227 | 44.15 |
Mtmr3 |
myotubularin related protein 3 |
3120 |
0.23 |
chrX_74424469_74424674 | 44.13 |
Ikbkg |
inhibitor of kappaB kinase gamma |
33 |
0.95 |
chr12_118189703_118189854 | 44.05 |
Dnah11 |
dynein, axonemal, heavy chain 11 |
9265 |
0.26 |
chr15_86108196_86108361 | 43.94 |
Gm15722 |
predicted gene 15722 |
18218 |
0.16 |
chr11_86607075_86607226 | 43.86 |
Vmp1 |
vacuole membrane protein 1 |
4855 |
0.17 |
chr15_91241061_91241237 | 43.67 |
CN725425 |
cDNA sequence CN725425 |
9571 |
0.24 |
chr9_99160889_99161053 | 43.60 |
Pik3cb |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta |
20350 |
0.15 |
chr10_100508281_100508447 | 43.58 |
Cep290 |
centrosomal protein 290 |
362 |
0.83 |
chr16_35807427_35807592 | 43.29 |
Gm26838 |
predicted gene, 26838 |
1437 |
0.31 |
chr17_24152285_24152529 | 43.12 |
Pdpk1 |
3-phosphoinositide dependent protein kinase 1 |
1483 |
0.21 |
chr7_25209148_25209349 | 42.88 |
Mir7048 |
microRNA 7048 |
8477 |
0.08 |
chr2_129232580_129232810 | 42.78 |
9830144P21Rik |
RIKEN cDNA 9830144P21 gene |
2116 |
0.17 |
chr11_120630106_120630318 | 42.64 |
Mafg |
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein G (avian) |
64 |
0.9 |
chr6_121101228_121101523 | 42.58 |
Mical3 |
microtubule associated monooxygenase, calponin and LIM domain containing 3 |
2160 |
0.26 |
chr6_38787954_38788133 | 42.55 |
Hipk2 |
homeodomain interacting protein kinase 2 |
30303 |
0.19 |
chr19_4045957_4046290 | 42.07 |
Gstp2 |
glutathione S-transferase, pi 2 |
100 |
0.9 |
chr7_100571034_100571205 | 42.02 |
Gm44648 |
predicted gene 44648 |
803 |
0.43 |
chr2_6263681_6263843 | 41.96 |
Gm13383 |
predicted gene 13383 |
6496 |
0.2 |
chr1_132365296_132365462 | 41.95 |
Tmcc2 |
transmembrane and coiled-coil domains 2 |
431 |
0.76 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
19.6 | 58.7 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
18.2 | 54.6 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
17.3 | 52.0 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
17.1 | 51.2 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
15.6 | 46.8 | GO:0052490 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
15.5 | 61.9 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
15.0 | 45.1 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
12.7 | 38.0 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
12.4 | 12.4 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
12.3 | 37.0 | GO:0043382 | positive regulation of memory T cell differentiation(GO:0043382) |
12.3 | 36.9 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
12.0 | 23.9 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
10.9 | 32.7 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
10.8 | 53.9 | GO:0015886 | heme transport(GO:0015886) |
10.4 | 31.2 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
10.2 | 30.6 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
9.9 | 59.5 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
9.6 | 28.7 | GO:1903751 | regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
9.5 | 28.5 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
9.4 | 28.1 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
8.8 | 26.3 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
8.5 | 33.9 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
8.4 | 25.2 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
8.3 | 25.0 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
8.2 | 33.0 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
8.1 | 24.3 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
7.9 | 23.8 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
7.9 | 23.7 | GO:1904504 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
7.8 | 31.4 | GO:0008228 | opsonization(GO:0008228) |
7.6 | 45.7 | GO:0015671 | oxygen transport(GO:0015671) |
7.3 | 36.6 | GO:0042435 | indole-containing compound biosynthetic process(GO:0042435) |
7.2 | 28.6 | GO:0032264 | IMP salvage(GO:0032264) |
7.1 | 21.3 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
6.8 | 33.9 | GO:0071494 | cellular response to UV-C(GO:0071494) |
6.7 | 27.0 | GO:0070836 | caveola assembly(GO:0070836) |
6.6 | 72.3 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
6.6 | 26.2 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
6.5 | 19.6 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
6.3 | 19.0 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
6.3 | 18.9 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
6.3 | 31.5 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
6.2 | 24.9 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
6.1 | 18.4 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
6.1 | 67.3 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
6.1 | 18.3 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
6.0 | 17.9 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
5.9 | 142.6 | GO:0033014 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
5.7 | 17.2 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
5.7 | 34.0 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
5.5 | 16.6 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
5.5 | 16.5 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
5.5 | 16.5 | GO:0030397 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
5.4 | 27.1 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
5.4 | 43.3 | GO:0006000 | fructose metabolic process(GO:0006000) |
5.2 | 5.2 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
5.2 | 10.3 | GO:0046149 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
5.0 | 20.2 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
4.9 | 19.8 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
4.9 | 14.7 | GO:0032077 | positive regulation of deoxyribonuclease activity(GO:0032077) |
4.9 | 14.7 | GO:0070627 | ferrous iron import(GO:0070627) |
4.8 | 67.5 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
4.8 | 19.2 | GO:1903238 | positive regulation of leukocyte tethering or rolling(GO:1903238) |
4.8 | 4.8 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
4.7 | 14.2 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
4.7 | 18.9 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
4.7 | 14.0 | GO:2000705 | regulation of dense core granule biogenesis(GO:2000705) |
4.6 | 37.2 | GO:0097286 | iron ion import(GO:0097286) |
4.6 | 4.6 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
4.6 | 18.4 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
4.5 | 18.1 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
4.5 | 4.5 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
4.5 | 13.4 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
4.5 | 93.7 | GO:0030224 | monocyte differentiation(GO:0030224) |
4.4 | 13.2 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
4.4 | 21.8 | GO:0015879 | carnitine transport(GO:0015879) |
4.3 | 13.0 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
4.3 | 13.0 | GO:0040031 | snRNA modification(GO:0040031) |
4.3 | 8.7 | GO:0042908 | xenobiotic transport(GO:0042908) |
4.3 | 12.9 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
4.3 | 12.9 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
4.2 | 4.2 | GO:0044854 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) |
4.2 | 25.4 | GO:0090527 | actin filament reorganization(GO:0090527) |
4.2 | 21.1 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
4.2 | 33.7 | GO:0071361 | cellular response to ethanol(GO:0071361) |
4.2 | 50.3 | GO:0033194 | response to hydroperoxide(GO:0033194) |
4.2 | 12.5 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
4.1 | 16.6 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
4.1 | 8.3 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
4.1 | 12.4 | GO:0015888 | thiamine transport(GO:0015888) |
4.1 | 12.3 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
4.1 | 12.2 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
4.1 | 12.2 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
4.1 | 32.5 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
4.0 | 12.1 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
4.0 | 20.2 | GO:0009115 | xanthine catabolic process(GO:0009115) |
4.0 | 16.1 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
4.0 | 12.1 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
4.0 | 4.0 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
4.0 | 31.9 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
4.0 | 16.0 | GO:0019532 | oxalate transport(GO:0019532) |
3.9 | 15.8 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
3.9 | 15.6 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
3.9 | 23.4 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
3.9 | 11.7 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
3.9 | 7.8 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
3.9 | 19.4 | GO:0031659 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
3.9 | 3.9 | GO:0072675 | osteoclast fusion(GO:0072675) |
3.8 | 23.1 | GO:1904415 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
3.8 | 19.1 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
3.8 | 15.2 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
3.8 | 15.2 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
3.7 | 3.7 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
3.7 | 11.1 | GO:0034136 | negative regulation of toll-like receptor 2 signaling pathway(GO:0034136) |
3.7 | 7.4 | GO:0006524 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
3.7 | 25.7 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
3.6 | 10.9 | GO:0002432 | granuloma formation(GO:0002432) |
3.6 | 10.9 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
3.6 | 3.6 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
3.6 | 10.8 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
3.6 | 10.8 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
3.6 | 21.5 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
3.6 | 14.3 | GO:0048625 | myoblast fate commitment(GO:0048625) |
3.5 | 14.0 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
3.5 | 14.0 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
3.5 | 7.0 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
3.5 | 10.5 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
3.5 | 27.7 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
3.5 | 10.4 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
3.5 | 6.9 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
3.5 | 24.2 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
3.4 | 10.2 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
3.4 | 17.0 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
3.3 | 3.3 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
3.3 | 16.6 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
3.3 | 16.5 | GO:0018101 | protein citrullination(GO:0018101) |
3.3 | 6.6 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
3.3 | 6.5 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
3.3 | 19.6 | GO:0051013 | microtubule severing(GO:0051013) |
3.2 | 6.4 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
3.2 | 32.0 | GO:0007097 | nuclear migration(GO:0007097) |
3.2 | 35.1 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
3.2 | 9.5 | GO:0070268 | cornification(GO:0070268) |
3.2 | 15.9 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
3.2 | 12.6 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
3.2 | 104.1 | GO:0006749 | glutathione metabolic process(GO:0006749) |
3.1 | 15.7 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
3.1 | 9.4 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
3.1 | 46.9 | GO:0035855 | megakaryocyte development(GO:0035855) |
3.1 | 9.4 | GO:0007529 | establishment of synaptic specificity at neuromuscular junction(GO:0007529) |
3.1 | 15.5 | GO:0032324 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
3.1 | 9.3 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
3.1 | 12.4 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
3.1 | 18.5 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
3.1 | 18.4 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
3.1 | 9.2 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
3.1 | 12.2 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
3.1 | 24.4 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
3.0 | 12.1 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
3.0 | 9.1 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
3.0 | 6.0 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
3.0 | 6.0 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
3.0 | 18.1 | GO:0007220 | Notch receptor processing(GO:0007220) |
3.0 | 9.0 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
3.0 | 6.0 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
3.0 | 26.7 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
3.0 | 8.9 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
2.9 | 14.7 | GO:0090343 | positive regulation of cell aging(GO:0090343) |
2.9 | 2.9 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
2.9 | 8.8 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
2.9 | 23.4 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
2.9 | 2.9 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
2.9 | 11.5 | GO:2000196 | positive regulation of female gonad development(GO:2000196) |
2.9 | 17.3 | GO:0016266 | O-glycan processing(GO:0016266) |
2.9 | 23.0 | GO:0006012 | galactose metabolic process(GO:0006012) |
2.9 | 17.2 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
2.9 | 2.9 | GO:0010980 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
2.9 | 34.4 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
2.9 | 8.6 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
2.9 | 14.3 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
2.8 | 5.7 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) |
2.8 | 54.1 | GO:0006301 | postreplication repair(GO:0006301) |
2.8 | 2.8 | GO:1900104 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
2.8 | 5.6 | GO:0070350 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
2.8 | 11.3 | GO:0000237 | leptotene(GO:0000237) |
2.8 | 8.4 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
2.8 | 61.6 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
2.8 | 5.6 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
2.8 | 19.6 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
2.8 | 8.4 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
2.8 | 13.9 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
2.8 | 8.3 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
2.8 | 5.5 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
2.8 | 2.8 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
2.8 | 19.3 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
2.7 | 2.7 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
2.7 | 27.3 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
2.7 | 2.7 | GO:0051310 | metaphase plate congression(GO:0051310) |
2.7 | 2.7 | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
2.7 | 5.4 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
2.7 | 21.7 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
2.7 | 18.9 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
2.7 | 16.1 | GO:2000258 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
2.7 | 8.0 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
2.7 | 18.6 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
2.7 | 23.9 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
2.7 | 13.3 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
2.6 | 5.3 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
2.6 | 31.5 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
2.6 | 5.2 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
2.6 | 7.9 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
2.6 | 7.8 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
2.6 | 5.2 | GO:1903626 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
2.6 | 2.6 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
2.6 | 7.8 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
2.6 | 5.2 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
2.6 | 10.3 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
2.6 | 2.6 | GO:0060128 | corticotropin hormone secreting cell differentiation(GO:0060128) |
2.6 | 7.7 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
2.6 | 10.3 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
2.6 | 5.1 | GO:0060319 | primitive erythrocyte differentiation(GO:0060319) |
2.6 | 28.2 | GO:0035879 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
2.6 | 12.8 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
2.5 | 17.8 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
2.5 | 20.3 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
2.5 | 7.6 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
2.5 | 78.2 | GO:0035058 | nonmotile primary cilium assembly(GO:0035058) |
2.5 | 10.0 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
2.5 | 5.0 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
2.5 | 5.0 | GO:0043622 | cortical microtubule organization(GO:0043622) |
2.5 | 14.8 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
2.5 | 4.9 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
2.5 | 4.9 | GO:1903286 | regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
2.5 | 9.8 | GO:0006742 | NADP catabolic process(GO:0006742) |
2.4 | 7.3 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
2.4 | 12.2 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
2.4 | 9.8 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
2.4 | 12.2 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
2.4 | 7.3 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
2.4 | 4.9 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
2.4 | 2.4 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
2.4 | 21.9 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
2.4 | 2.4 | GO:0009750 | response to fructose(GO:0009750) cellular response to fructose stimulus(GO:0071332) |
2.4 | 16.8 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
2.4 | 2.4 | GO:1990441 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
2.4 | 14.3 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
2.4 | 2.4 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
2.4 | 9.5 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
2.4 | 2.4 | GO:0031268 | pseudopodium organization(GO:0031268) |
2.4 | 4.7 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
2.4 | 4.7 | GO:0010912 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
2.4 | 11.8 | GO:0003352 | regulation of cilium movement(GO:0003352) regulation of cilium beat frequency(GO:0003356) |
2.4 | 7.1 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
2.4 | 9.4 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
2.3 | 18.5 | GO:0046686 | response to cadmium ion(GO:0046686) |
2.3 | 11.6 | GO:0002861 | regulation of inflammatory response to antigenic stimulus(GO:0002861) |
2.3 | 6.9 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
2.3 | 6.9 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
2.3 | 9.2 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
2.3 | 2.3 | GO:0010887 | negative regulation of cholesterol storage(GO:0010887) |
2.3 | 6.9 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
2.3 | 6.8 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
2.3 | 9.1 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
2.3 | 6.8 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
2.3 | 2.3 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
2.2 | 11.2 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
2.2 | 4.5 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
2.2 | 8.9 | GO:1901977 | negative regulation of cell cycle checkpoint(GO:1901977) |
2.2 | 4.4 | GO:0042505 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
2.2 | 6.7 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
2.2 | 6.7 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
2.2 | 11.1 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
2.2 | 13.2 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
2.2 | 2.2 | GO:0031620 | vein smooth muscle contraction(GO:0014826) regulation of fever generation(GO:0031620) |
2.2 | 4.4 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
2.2 | 15.4 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
2.2 | 6.6 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
2.2 | 8.7 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
2.2 | 4.3 | GO:0002326 | B cell lineage commitment(GO:0002326) |
2.1 | 4.3 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
2.1 | 17.1 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
2.1 | 4.3 | GO:2000726 | negative regulation of cardiac muscle cell differentiation(GO:2000726) |
2.1 | 4.3 | GO:1904688 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
2.1 | 19.1 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
2.1 | 6.4 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
2.1 | 4.2 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
2.1 | 16.9 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
2.1 | 12.7 | GO:0040016 | embryonic cleavage(GO:0040016) |
2.1 | 14.8 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
2.1 | 31.6 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
2.1 | 6.3 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
2.1 | 12.6 | GO:0032782 | bile acid secretion(GO:0032782) |
2.1 | 62.9 | GO:0030330 | DNA damage response, signal transduction by p53 class mediator(GO:0030330) |
2.1 | 8.4 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
2.1 | 6.3 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
2.1 | 6.3 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
2.1 | 8.3 | GO:0072672 | neutrophil extravasation(GO:0072672) |
2.1 | 8.3 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
2.1 | 8.3 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
2.1 | 6.2 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
2.1 | 4.2 | GO:0060037 | pharyngeal system development(GO:0060037) |
2.1 | 8.3 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
2.1 | 6.2 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
2.1 | 18.5 | GO:0006903 | vesicle targeting(GO:0006903) |
2.1 | 2.1 | GO:2000143 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
2.1 | 6.2 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
2.1 | 12.3 | GO:0006561 | proline biosynthetic process(GO:0006561) |
2.0 | 8.2 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
2.0 | 2.0 | GO:0071224 | cellular response to peptidoglycan(GO:0071224) |
2.0 | 10.2 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
2.0 | 6.1 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
2.0 | 6.1 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
2.0 | 6.1 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
2.0 | 8.1 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
2.0 | 10.1 | GO:0000303 | response to superoxide(GO:0000303) |
2.0 | 4.0 | GO:0043173 | nucleotide salvage(GO:0043173) |
2.0 | 4.0 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
2.0 | 10.0 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
2.0 | 9.9 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
2.0 | 3.9 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
2.0 | 5.9 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
2.0 | 9.8 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
2.0 | 35.2 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
2.0 | 2.0 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
2.0 | 2.0 | GO:0031498 | chromatin disassembly(GO:0031498) |
2.0 | 7.8 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
1.9 | 1.9 | GO:0048769 | sarcomerogenesis(GO:0048769) |
1.9 | 21.3 | GO:0032310 | prostaglandin secretion(GO:0032310) |
1.9 | 9.7 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
1.9 | 3.9 | GO:0009182 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) |
1.9 | 7.7 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
1.9 | 13.5 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
1.9 | 7.7 | GO:0098535 | de novo centriole assembly(GO:0098535) |
1.9 | 13.5 | GO:0009992 | cellular water homeostasis(GO:0009992) |
1.9 | 26.9 | GO:0048821 | erythrocyte development(GO:0048821) |
1.9 | 9.6 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
1.9 | 1.9 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
1.9 | 3.8 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
1.9 | 9.5 | GO:0032570 | response to progesterone(GO:0032570) |
1.9 | 1.9 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
1.9 | 18.9 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
1.9 | 13.2 | GO:0070255 | regulation of mucus secretion(GO:0070255) |
1.9 | 9.4 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
1.9 | 3.8 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
1.9 | 3.8 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
1.9 | 20.7 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
1.9 | 3.8 | GO:0044004 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
1.9 | 3.8 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
1.9 | 7.5 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
1.9 | 5.6 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
1.9 | 9.4 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
1.9 | 1.9 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
1.9 | 22.5 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
1.9 | 5.6 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
1.9 | 7.5 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
1.9 | 5.6 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
1.9 | 5.6 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
1.8 | 35.1 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
1.8 | 12.9 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
1.8 | 7.4 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
1.8 | 1.8 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
1.8 | 1.8 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
1.8 | 5.5 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
1.8 | 1.8 | GO:0035553 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) oxidative demethylation(GO:0070989) |
1.8 | 5.4 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
1.8 | 1.8 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
1.8 | 10.8 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
1.8 | 7.2 | GO:0006004 | fucose metabolic process(GO:0006004) |
1.8 | 9.0 | GO:0070475 | rRNA base methylation(GO:0070475) |
1.8 | 16.1 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
1.8 | 12.4 | GO:0031033 | myosin filament organization(GO:0031033) |
1.8 | 10.6 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
1.8 | 5.3 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
1.8 | 10.6 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
1.8 | 5.3 | GO:0033227 | dsRNA transport(GO:0033227) |
1.8 | 1.8 | GO:0043379 | memory T cell differentiation(GO:0043379) |
1.8 | 14.1 | GO:0032060 | bleb assembly(GO:0032060) |
1.8 | 7.0 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
1.8 | 3.5 | GO:0051972 | regulation of telomerase activity(GO:0051972) |
1.8 | 7.0 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
1.7 | 15.7 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
1.7 | 87.3 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
1.7 | 12.2 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
1.7 | 8.7 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
1.7 | 3.5 | GO:0018992 | germ-line sex determination(GO:0018992) |
1.7 | 1.7 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
1.7 | 6.9 | GO:0042168 | heme metabolic process(GO:0042168) |
1.7 | 36.2 | GO:0016578 | histone deubiquitination(GO:0016578) |
1.7 | 12.1 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
1.7 | 1.7 | GO:0018904 | ether metabolic process(GO:0018904) |
1.7 | 63.2 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
1.7 | 8.5 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
1.7 | 1.7 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
1.7 | 8.5 | GO:0033623 | regulation of integrin activation(GO:0033623) |
1.7 | 1.7 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
1.7 | 22.0 | GO:0006415 | translational termination(GO:0006415) |
1.7 | 3.4 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
1.7 | 3.4 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
1.7 | 3.4 | GO:0010039 | response to iron ion(GO:0010039) |
1.7 | 8.4 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
1.7 | 5.0 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
1.7 | 3.3 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
1.7 | 3.3 | GO:0071499 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
1.7 | 5.0 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
1.7 | 5.0 | GO:1902065 | response to L-glutamate(GO:1902065) |
1.7 | 5.0 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
1.6 | 8.2 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
1.6 | 6.6 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
1.6 | 13.2 | GO:0051187 | coenzyme catabolic process(GO:0009109) cofactor catabolic process(GO:0051187) |
1.6 | 32.9 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
1.6 | 3.3 | GO:0061620 | glycolytic process through glucose-6-phosphate(GO:0061620) |
1.6 | 3.3 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
1.6 | 4.9 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
1.6 | 1.6 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
1.6 | 4.9 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
1.6 | 4.9 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
1.6 | 6.5 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
1.6 | 14.5 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
1.6 | 4.8 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
1.6 | 3.2 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
1.6 | 17.7 | GO:0048753 | melanosome organization(GO:0032438) pigment granule organization(GO:0048753) |
1.6 | 3.2 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
1.6 | 11.1 | GO:0030575 | nuclear body organization(GO:0030575) |
1.6 | 7.9 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
1.6 | 1.6 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
1.6 | 9.5 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
1.6 | 4.7 | GO:1901836 | regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
1.6 | 1.6 | GO:0030223 | neutrophil differentiation(GO:0030223) |
1.6 | 3.1 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
1.6 | 4.7 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
1.6 | 9.3 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
1.6 | 23.3 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
1.6 | 4.7 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
1.5 | 6.2 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
1.5 | 29.2 | GO:0031648 | protein destabilization(GO:0031648) |
1.5 | 7.7 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
1.5 | 7.7 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
1.5 | 3.1 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
1.5 | 7.7 | GO:0006559 | L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
1.5 | 13.8 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
1.5 | 3.0 | GO:0002447 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
1.5 | 6.1 | GO:0006684 | sphingomyelin metabolic process(GO:0006684) |
1.5 | 1.5 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
1.5 | 4.5 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
1.5 | 1.5 | GO:0010226 | response to lithium ion(GO:0010226) cellular response to lithium ion(GO:0071285) |
1.5 | 1.5 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
1.5 | 7.5 | GO:0000022 | mitotic spindle elongation(GO:0000022) spindle midzone assembly(GO:0051255) mitotic spindle midzone assembly(GO:0051256) |
1.5 | 6.0 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
1.5 | 6.0 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
1.5 | 1.5 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
1.5 | 4.5 | GO:0023021 | termination of signal transduction(GO:0023021) |
1.5 | 7.5 | GO:0045332 | phospholipid translocation(GO:0045332) |
1.5 | 10.4 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
1.5 | 10.4 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
1.5 | 7.4 | GO:0021764 | amygdala development(GO:0021764) |
1.5 | 1.5 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
1.5 | 1.5 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
1.5 | 31.0 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
1.5 | 1.5 | GO:0048021 | regulation of melanin biosynthetic process(GO:0048021) regulation of secondary metabolite biosynthetic process(GO:1900376) |
1.5 | 2.9 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
1.5 | 2.9 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
1.5 | 4.4 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
1.5 | 13.2 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
1.5 | 5.9 | GO:0051031 | tRNA transport(GO:0051031) |
1.5 | 4.4 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
1.5 | 4.4 | GO:0034476 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) |
1.5 | 5.8 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
1.5 | 2.9 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
1.5 | 4.4 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
1.5 | 37.7 | GO:0006801 | superoxide metabolic process(GO:0006801) |
1.5 | 1.5 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
1.4 | 4.3 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
1.4 | 24.6 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
1.4 | 4.3 | GO:0042126 | nitrate metabolic process(GO:0042126) |
1.4 | 2.9 | GO:0015884 | folic acid transport(GO:0015884) |
1.4 | 13.0 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
1.4 | 2.9 | GO:0032642 | regulation of chemokine production(GO:0032642) |
1.4 | 2.9 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
1.4 | 2.9 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
1.4 | 5.8 | GO:0050812 | regulation of acyl-CoA biosynthetic process(GO:0050812) |
1.4 | 7.2 | GO:0001842 | neural fold formation(GO:0001842) |
1.4 | 7.2 | GO:0046040 | IMP metabolic process(GO:0046040) |
1.4 | 2.9 | GO:1901799 | negative regulation of proteasomal protein catabolic process(GO:1901799) |
1.4 | 2.9 | GO:0050904 | diapedesis(GO:0050904) |
1.4 | 2.8 | GO:0010873 | positive regulation of cholesterol esterification(GO:0010873) |
1.4 | 29.9 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
1.4 | 32.7 | GO:0030574 | collagen catabolic process(GO:0030574) |
1.4 | 2.8 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
1.4 | 4.3 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
1.4 | 11.3 | GO:0051014 | actin filament severing(GO:0051014) |
1.4 | 1.4 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
1.4 | 11.3 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
1.4 | 2.8 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
1.4 | 5.6 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
1.4 | 1.4 | GO:0051341 | regulation of oxidoreductase activity(GO:0051341) |
1.4 | 2.8 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
1.4 | 1.4 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
1.4 | 2.8 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
1.4 | 2.8 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
1.4 | 8.3 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
1.4 | 1.4 | GO:0031860 | telomeric loop formation(GO:0031627) telomeric 3' overhang formation(GO:0031860) |
1.4 | 9.6 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
1.4 | 9.6 | GO:0051451 | myoblast migration(GO:0051451) |
1.4 | 5.5 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
1.4 | 4.1 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
1.4 | 1.4 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
1.4 | 1.4 | GO:0010165 | response to X-ray(GO:0010165) |
1.4 | 8.2 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
1.4 | 6.8 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
1.4 | 4.1 | GO:0018094 | protein polyglycylation(GO:0018094) |
1.4 | 35.2 | GO:0045604 | regulation of epidermal cell differentiation(GO:0045604) |
1.3 | 24.1 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
1.3 | 18.7 | GO:0006829 | zinc II ion transport(GO:0006829) |
1.3 | 1.3 | GO:0042772 | DNA damage response, signal transduction resulting in transcription(GO:0042772) |
1.3 | 2.7 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
1.3 | 2.7 | GO:0010040 | response to iron(II) ion(GO:0010040) |
1.3 | 2.7 | GO:0042506 | tyrosine phosphorylation of Stat5 protein(GO:0042506) |
1.3 | 1.3 | GO:0042921 | glucocorticoid receptor signaling pathway(GO:0042921) |
1.3 | 2.6 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
1.3 | 4.0 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
1.3 | 4.0 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
1.3 | 4.0 | GO:0006203 | dGTP catabolic process(GO:0006203) |
1.3 | 2.6 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
1.3 | 23.8 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
1.3 | 3.9 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
1.3 | 2.6 | GO:0030449 | regulation of complement activation(GO:0030449) |
1.3 | 5.2 | GO:0036089 | cleavage furrow formation(GO:0036089) |
1.3 | 1.3 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
1.3 | 2.6 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
1.3 | 3.9 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
1.3 | 2.6 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
1.3 | 7.7 | GO:0071318 | cellular response to ATP(GO:0071318) |
1.3 | 3.9 | GO:1903337 | positive regulation of vacuolar transport(GO:1903337) |
1.3 | 5.2 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
1.3 | 10.3 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
1.3 | 1.3 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
1.3 | 10.3 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
1.3 | 3.9 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
1.3 | 1.3 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
1.3 | 14.0 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
1.3 | 3.8 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
1.3 | 1.3 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
1.3 | 12.7 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
1.3 | 5.1 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
1.3 | 15.2 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
1.3 | 2.5 | GO:0070827 | chromatin maintenance(GO:0070827) |
1.3 | 6.3 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
1.3 | 8.8 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
1.3 | 2.5 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
1.3 | 6.3 | GO:0000103 | sulfate assimilation(GO:0000103) |
1.3 | 3.8 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
1.3 | 2.5 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
1.3 | 1.3 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
1.3 | 5.0 | GO:0001955 | blood vessel maturation(GO:0001955) |
1.3 | 1.3 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
1.3 | 3.8 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
1.3 | 1.3 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
1.2 | 7.5 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
1.2 | 3.7 | GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
1.2 | 2.5 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
1.2 | 3.7 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
1.2 | 5.0 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
1.2 | 6.2 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) |
1.2 | 5.0 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
1.2 | 8.7 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
1.2 | 3.7 | GO:0010612 | regulation of cardiac muscle adaptation(GO:0010612) regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) |
1.2 | 5.0 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
1.2 | 3.7 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
1.2 | 2.5 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
1.2 | 16.1 | GO:0006817 | phosphate ion transport(GO:0006817) |
1.2 | 2.5 | GO:0007296 | vitellogenesis(GO:0007296) |
1.2 | 11.1 | GO:0035510 | DNA dealkylation(GO:0035510) |
1.2 | 3.7 | GO:0046929 | negative regulation of neurotransmitter secretion(GO:0046929) |
1.2 | 1.2 | GO:2000564 | regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) |
1.2 | 8.6 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
1.2 | 11.0 | GO:0035455 | response to interferon-alpha(GO:0035455) |
1.2 | 3.7 | GO:0072530 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
1.2 | 1.2 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
1.2 | 13.2 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
1.2 | 3.6 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
1.2 | 15.6 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
1.2 | 1.2 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
1.2 | 1.2 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
1.2 | 2.4 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
1.2 | 11.9 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
1.2 | 21.4 | GO:0006308 | DNA catabolic process(GO:0006308) |
1.2 | 3.6 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
1.2 | 42.7 | GO:0006611 | protein export from nucleus(GO:0006611) |
1.2 | 3.5 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
1.2 | 4.7 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
1.2 | 4.7 | GO:0044351 | macropinocytosis(GO:0044351) |
1.2 | 3.5 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
1.2 | 3.5 | GO:1901533 | negative regulation of hematopoietic progenitor cell differentiation(GO:1901533) |
1.2 | 21.0 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
1.2 | 4.7 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
1.2 | 4.7 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
1.2 | 9.3 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
1.2 | 2.3 | GO:0046931 | pore complex assembly(GO:0046931) |
1.2 | 1.2 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
1.2 | 11.7 | GO:0070875 | positive regulation of glycogen metabolic process(GO:0070875) |
1.2 | 1.2 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
1.2 | 5.8 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
1.2 | 8.1 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
1.1 | 1.1 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
1.1 | 2.3 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
1.1 | 1.1 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
1.1 | 4.5 | GO:0046490 | isopentenyl diphosphate metabolic process(GO:0046490) |
1.1 | 3.4 | GO:0001803 | type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
1.1 | 1.1 | GO:0060125 | amylase secretion(GO:0036394) negative regulation of growth hormone secretion(GO:0060125) |
1.1 | 4.5 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
1.1 | 4.5 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
1.1 | 4.5 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
1.1 | 1.1 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
1.1 | 2.2 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
1.1 | 3.3 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
1.1 | 1.1 | GO:0006059 | hexitol metabolic process(GO:0006059) |
1.1 | 3.3 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
1.1 | 8.8 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
1.1 | 1.1 | GO:0031049 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
1.1 | 6.6 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) negative regulation of adherens junction organization(GO:1903392) |
1.1 | 6.6 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
1.1 | 7.7 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
1.1 | 2.2 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
1.1 | 2.2 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
1.1 | 3.3 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
1.1 | 3.3 | GO:0000087 | mitotic M phase(GO:0000087) |
1.1 | 6.5 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
1.1 | 2.2 | GO:0044805 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) single-organism membrane invagination(GO:1902534) |
1.1 | 3.3 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
1.1 | 3.3 | GO:0045821 | positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
1.1 | 1.1 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
1.1 | 4.3 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
1.1 | 18.5 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
1.1 | 3.3 | GO:0046060 | dATP metabolic process(GO:0046060) |
1.1 | 2.2 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
1.1 | 4.3 | GO:0009437 | carnitine metabolic process(GO:0009437) |
1.1 | 7.6 | GO:0046599 | regulation of centriole replication(GO:0046599) |
1.1 | 7.6 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
1.1 | 3.2 | GO:0051462 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) |
1.1 | 4.3 | GO:0044597 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
1.1 | 7.6 | GO:0042770 | signal transduction in response to DNA damage(GO:0042770) |
1.1 | 2.2 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
1.1 | 13.9 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
1.1 | 10.7 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
1.1 | 1.1 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
1.1 | 3.2 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
1.1 | 10.6 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
1.1 | 2.1 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
1.1 | 7.4 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
1.1 | 22.3 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
1.1 | 6.4 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
1.1 | 2.1 | GO:0009070 | serine family amino acid biosynthetic process(GO:0009070) |
1.1 | 4.2 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) |
1.1 | 1.1 | GO:0071725 | response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
1.1 | 31.7 | GO:0007091 | metaphase/anaphase transition of mitotic cell cycle(GO:0007091) metaphase/anaphase transition of cell cycle(GO:0044784) |
1.1 | 3.2 | GO:0006116 | NADH oxidation(GO:0006116) |
1.0 | 7.3 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
1.0 | 1.0 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
1.0 | 1.0 | GO:0014735 | regulation of muscle atrophy(GO:0014735) |
1.0 | 7.3 | GO:0071435 | potassium ion export(GO:0071435) |
1.0 | 2.1 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
1.0 | 8.3 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
1.0 | 11.3 | GO:0033273 | response to vitamin(GO:0033273) |
1.0 | 2.1 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
1.0 | 3.1 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
1.0 | 3.1 | GO:0031642 | negative regulation of myelination(GO:0031642) |
1.0 | 4.1 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
1.0 | 5.1 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
1.0 | 7.2 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
1.0 | 1.0 | GO:2000482 | regulation of interleukin-8 secretion(GO:2000482) |
1.0 | 23.5 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
1.0 | 3.1 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
1.0 | 4.1 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
1.0 | 9.2 | GO:0009301 | snRNA transcription(GO:0009301) |
1.0 | 2.0 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
1.0 | 2.0 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
1.0 | 5.1 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
1.0 | 3.0 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
1.0 | 6.1 | GO:0097033 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
1.0 | 1.0 | GO:0006273 | lagging strand elongation(GO:0006273) |
1.0 | 5.0 | GO:0021930 | cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
1.0 | 5.0 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
1.0 | 7.0 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
1.0 | 5.0 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
1.0 | 42.6 | GO:0051225 | spindle assembly(GO:0051225) |
1.0 | 5.0 | GO:0031507 | heterochromatin assembly(GO:0031507) |
1.0 | 8.9 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
1.0 | 1.0 | GO:0001705 | ectoderm formation(GO:0001705) |
1.0 | 1.0 | GO:0032204 | regulation of telomere maintenance(GO:0032204) |
1.0 | 1.0 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
1.0 | 2.9 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
1.0 | 2.0 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
1.0 | 1.0 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
1.0 | 1.0 | GO:0070076 | histone lysine demethylation(GO:0070076) |
1.0 | 2.9 | GO:0006056 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule metabolic process(GO:0044036) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) cell wall organization or biogenesis(GO:0071554) |
1.0 | 1.0 | GO:0070949 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
1.0 | 1.0 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
1.0 | 2.9 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
1.0 | 1.0 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
1.0 | 10.6 | GO:0006968 | cellular defense response(GO:0006968) |
1.0 | 9.6 | GO:0051904 | pigment granule transport(GO:0051904) |
1.0 | 1.0 | GO:0071637 | monocyte chemotactic protein-1 production(GO:0071605) regulation of monocyte chemotactic protein-1 production(GO:0071637) |
1.0 | 1.0 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
1.0 | 1.9 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
1.0 | 1.9 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
1.0 | 5.7 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
1.0 | 2.9 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
1.0 | 1.9 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
1.0 | 3.8 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
1.0 | 6.7 | GO:0090305 | nucleic acid phosphodiester bond hydrolysis(GO:0090305) |
1.0 | 1.0 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
1.0 | 2.9 | GO:0015819 | lysine transport(GO:0015819) |
0.9 | 11.4 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.9 | 4.7 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.9 | 1.9 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.9 | 0.9 | GO:0090177 | establishment of planar polarity involved in neural tube closure(GO:0090177) |
0.9 | 15.0 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.9 | 2.8 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.9 | 2.8 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.9 | 11.2 | GO:0006298 | mismatch repair(GO:0006298) |
0.9 | 0.9 | GO:1902075 | cellular response to salt(GO:1902075) |
0.9 | 1.9 | GO:0043396 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) |
0.9 | 0.9 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
0.9 | 1.9 | GO:0035624 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.9 | 1.9 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.9 | 2.8 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.9 | 0.9 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.9 | 1.9 | GO:0036514 | dopaminergic neuron axon guidance(GO:0036514) planar cell polarity pathway involved in axon guidance(GO:1904938) |
0.9 | 1.9 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
0.9 | 0.9 | GO:1904037 | positive regulation of epithelial cell apoptotic process(GO:1904037) |
0.9 | 1.8 | GO:0009838 | abscission(GO:0009838) |
0.9 | 1.8 | GO:0051985 | negative regulation of chromosome segregation(GO:0051985) |
0.9 | 8.2 | GO:0043486 | histone exchange(GO:0043486) |
0.9 | 1.8 | GO:1902808 | positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.9 | 6.4 | GO:0051383 | kinetochore assembly(GO:0051382) kinetochore organization(GO:0051383) |
0.9 | 1.8 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.9 | 0.9 | GO:0098915 | membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) positive regulation of actin filament-based movement(GO:1903116) |
0.9 | 9.1 | GO:1903318 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
0.9 | 2.7 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.9 | 0.9 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.9 | 0.9 | GO:0003164 | His-Purkinje system development(GO:0003164) |
0.9 | 38.1 | GO:0000956 | nuclear-transcribed mRNA catabolic process(GO:0000956) |
0.9 | 1.8 | GO:0046148 | pigment biosynthetic process(GO:0046148) |
0.9 | 6.3 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.9 | 2.7 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.9 | 2.7 | GO:0034724 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.9 | 4.5 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.9 | 1.8 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.9 | 8.1 | GO:0046457 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.9 | 2.7 | GO:1902993 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.9 | 1.8 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.9 | 0.9 | GO:0070922 | small RNA loading onto RISC(GO:0070922) |
0.9 | 0.9 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.9 | 2.7 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.9 | 6.2 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.9 | 0.9 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.9 | 3.5 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.9 | 0.9 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.9 | 8.8 | GO:0048741 | skeletal muscle fiber development(GO:0048741) |
0.9 | 28.1 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.9 | 5.3 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.9 | 2.6 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.9 | 1.7 | GO:0030826 | regulation of cGMP biosynthetic process(GO:0030826) |
0.9 | 1.7 | GO:0002215 | defense response to nematode(GO:0002215) |
0.9 | 5.2 | GO:0051639 | actin filament network formation(GO:0051639) |
0.9 | 2.6 | GO:0033762 | response to glucagon(GO:0033762) |
0.9 | 2.6 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.9 | 1.7 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.9 | 1.7 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.9 | 3.5 | GO:0043144 | snoRNA processing(GO:0043144) |
0.9 | 0.9 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.9 | 0.9 | GO:0033598 | mammary gland epithelial cell proliferation(GO:0033598) |
0.9 | 6.0 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.9 | 0.9 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) |
0.9 | 1.7 | GO:0045730 | respiratory burst(GO:0045730) |
0.9 | 1.7 | GO:0060242 | contact inhibition(GO:0060242) |
0.9 | 18.0 | GO:1900047 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.9 | 1.7 | GO:0006868 | glutamine transport(GO:0006868) |
0.9 | 2.6 | GO:0007525 | somatic muscle development(GO:0007525) |
0.9 | 3.4 | GO:1904814 | regulation of protein localization to chromosome, telomeric region(GO:1904814) positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
0.9 | 0.9 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.8 | 1.7 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.8 | 2.5 | GO:0015825 | L-serine transport(GO:0015825) |
0.8 | 3.4 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
0.8 | 1.7 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.8 | 8.4 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.8 | 8.4 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.8 | 3.3 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.8 | 5.0 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.8 | 7.4 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.8 | 3.3 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.8 | 1.6 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.8 | 5.7 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.8 | 4.1 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.8 | 1.6 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.8 | 3.2 | GO:0010390 | histone monoubiquitination(GO:0010390) |
0.8 | 1.6 | GO:0046039 | GTP metabolic process(GO:0046039) |
0.8 | 9.7 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.8 | 2.4 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.8 | 3.2 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.8 | 4.0 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.8 | 6.4 | GO:0044117 | growth involved in symbiotic interaction(GO:0044110) growth of symbiont involved in interaction with host(GO:0044116) growth of symbiont in host(GO:0044117) |
0.8 | 2.4 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.8 | 2.4 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.8 | 1.6 | GO:0051029 | rRNA transport(GO:0051029) |
0.8 | 1.6 | GO:1900746 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902547) |
0.8 | 1.6 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.8 | 0.8 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) |
0.8 | 1.6 | GO:0002086 | diaphragm contraction(GO:0002086) involuntary skeletal muscle contraction(GO:0003011) |
0.8 | 5.5 | GO:0006241 | CTP biosynthetic process(GO:0006241) CTP metabolic process(GO:0046036) |
0.8 | 1.6 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.8 | 3.1 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.8 | 7.1 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.8 | 0.8 | GO:0021886 | hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) |
0.8 | 16.5 | GO:0007569 | cell aging(GO:0007569) |
0.8 | 1.6 | GO:0035357 | peroxisome proliferator activated receptor signaling pathway(GO:0035357) |
0.8 | 1.6 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.8 | 3.1 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.8 | 9.4 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.8 | 19.5 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.8 | 1.6 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.8 | 1.6 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
0.8 | 1.6 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.8 | 4.7 | GO:0071696 | ectodermal placode formation(GO:0060788) ectodermal placode development(GO:0071696) ectodermal placode morphogenesis(GO:0071697) |
0.8 | 7.8 | GO:0014068 | positive regulation of phosphatidylinositol 3-kinase signaling(GO:0014068) |
0.8 | 1.5 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.8 | 0.8 | GO:0002349 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.8 | 3.1 | GO:0051026 | chiasma assembly(GO:0051026) |
0.8 | 1.5 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.8 | 0.8 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.8 | 2.3 | GO:0015889 | cobalamin transport(GO:0015889) |
0.8 | 6.1 | GO:0072662 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.8 | 3.8 | GO:0032099 | negative regulation of appetite(GO:0032099) |
0.8 | 4.6 | GO:0006743 | ubiquinone metabolic process(GO:0006743) |
0.8 | 2.3 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.8 | 6.1 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.8 | 3.8 | GO:0043084 | penile erection(GO:0043084) |
0.8 | 2.3 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.8 | 4.5 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.8 | 2.3 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.8 | 0.8 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.8 | 0.8 | GO:1903416 | response to glycoside(GO:1903416) |
0.8 | 1.5 | GO:0006907 | pinocytosis(GO:0006907) |
0.8 | 1.5 | GO:0090289 | regulation of osteoclast proliferation(GO:0090289) |
0.8 | 1.5 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.7 | 6.7 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.7 | 3.0 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.7 | 11.2 | GO:0019915 | lipid storage(GO:0019915) |
0.7 | 0.7 | GO:0003289 | atrial septum primum morphogenesis(GO:0003289) |
0.7 | 1.5 | GO:0031442 | positive regulation of mRNA 3'-end processing(GO:0031442) |
0.7 | 4.5 | GO:0006026 | aminoglycan catabolic process(GO:0006026) |
0.7 | 14.1 | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
0.7 | 14.8 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.7 | 4.4 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.7 | 0.7 | GO:0002424 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
0.7 | 1.5 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.7 | 2.9 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.7 | 0.7 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.7 | 2.2 | GO:0048478 | replication fork protection(GO:0048478) |
0.7 | 2.2 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.7 | 5.1 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.7 | 2.2 | GO:0007000 | nucleolus organization(GO:0007000) |
0.7 | 0.7 | GO:0034204 | lipid translocation(GO:0034204) |
0.7 | 1.4 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.7 | 2.2 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.7 | 0.7 | GO:1990774 | regulation of tumor necrosis factor secretion(GO:1904467) tumor necrosis factor secretion(GO:1990774) |
0.7 | 0.7 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
0.7 | 1.4 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.7 | 1.4 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.7 | 13.6 | GO:0006284 | base-excision repair(GO:0006284) |
0.7 | 17.2 | GO:0006096 | glycolytic process(GO:0006096) |
0.7 | 2.1 | GO:0051788 | response to misfolded protein(GO:0051788) |
0.7 | 4.3 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.7 | 12.8 | GO:0007173 | epidermal growth factor receptor signaling pathway(GO:0007173) |
0.7 | 3.6 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.7 | 5.0 | GO:0045740 | positive regulation of DNA replication(GO:0045740) |
0.7 | 2.8 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.7 | 2.8 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.7 | 2.1 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.7 | 0.7 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.7 | 2.1 | GO:0006119 | oxidative phosphorylation(GO:0006119) |
0.7 | 3.5 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.7 | 5.6 | GO:0016925 | protein sumoylation(GO:0016925) |
0.7 | 1.4 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.7 | 2.8 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.7 | 7.0 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.7 | 5.6 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.7 | 8.3 | GO:0050832 | defense response to fungus(GO:0050832) |
0.7 | 2.8 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.7 | 2.1 | GO:0070230 | positive regulation of lymphocyte apoptotic process(GO:0070230) |
0.7 | 1.4 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
0.7 | 1.4 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.7 | 2.1 | GO:1903960 | negative regulation of anion transmembrane transport(GO:1903960) |
0.7 | 2.8 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.7 | 6.9 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.7 | 5.5 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.7 | 1.4 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.7 | 0.7 | GO:0019682 | glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
0.7 | 6.9 | GO:0038061 | NIK/NF-kappaB signaling(GO:0038061) |
0.7 | 1.4 | GO:0009072 | aromatic amino acid family metabolic process(GO:0009072) |
0.7 | 0.7 | GO:0038034 | signal transduction in absence of ligand(GO:0038034) extrinsic apoptotic signaling pathway in absence of ligand(GO:0097192) |
0.7 | 3.4 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.7 | 3.4 | GO:1901984 | negative regulation of protein acetylation(GO:1901984) |
0.7 | 2.1 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.7 | 0.7 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.7 | 4.8 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.7 | 12.3 | GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity(GO:0043433) |
0.7 | 0.7 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.7 | 2.0 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.7 | 21.7 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.7 | 0.7 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
0.7 | 0.7 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.7 | 1.3 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.7 | 10.1 | GO:0033003 | regulation of mast cell activation(GO:0033003) |
0.7 | 1.3 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.7 | 0.7 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.7 | 5.4 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.7 | 3.3 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.7 | 6.0 | GO:0030539 | male genitalia development(GO:0030539) |
0.7 | 3.3 | GO:1903541 | regulation of exosomal secretion(GO:1903541) positive regulation of exosomal secretion(GO:1903543) |
0.7 | 2.0 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.7 | 12.0 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
0.7 | 4.0 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.7 | 2.6 | GO:0045141 | telomere tethering at nuclear periphery(GO:0034398) meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic telomere clustering(GO:0045141) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.7 | 4.6 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.7 | 1.3 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.7 | 1.3 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
0.7 | 1.3 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.7 | 2.6 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.7 | 1.3 | GO:0070723 | response to cholesterol(GO:0070723) |
0.7 | 1.3 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.7 | 1.3 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.7 | 0.7 | GO:0044800 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.7 | 1.3 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.7 | 1.3 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
0.7 | 0.7 | GO:0007398 | ectoderm development(GO:0007398) |
0.7 | 3.3 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.7 | 3.9 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.6 | 1.3 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.6 | 0.6 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.6 | 1.3 | GO:1903672 | positive regulation of sprouting angiogenesis(GO:1903672) |
0.6 | 1.9 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.6 | 1.3 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.6 | 1.3 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.6 | 1.3 | GO:0007144 | female meiosis I(GO:0007144) |
0.6 | 5.8 | GO:0098534 | centriole assembly(GO:0098534) |
0.6 | 5.1 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.6 | 0.6 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.6 | 1.3 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.6 | 1.9 | GO:0001835 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.6 | 0.6 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.6 | 1.9 | GO:0034105 | positive regulation of tissue remodeling(GO:0034105) |
0.6 | 1.9 | GO:0060547 | negative regulation of necrotic cell death(GO:0060547) |
0.6 | 1.3 | GO:0009084 | glutamine family amino acid biosynthetic process(GO:0009084) |
0.6 | 1.3 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
0.6 | 1.9 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.6 | 1.3 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
0.6 | 8.8 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.6 | 2.5 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.6 | 13.1 | GO:0043297 | apical junction assembly(GO:0043297) |
0.6 | 26.9 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.6 | 3.7 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.6 | 1.9 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.6 | 0.6 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.6 | 0.6 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.6 | 2.5 | GO:0006921 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
0.6 | 8.0 | GO:0017145 | stem cell division(GO:0017145) |
0.6 | 1.8 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
0.6 | 0.6 | GO:0015810 | aspartate transport(GO:0015810) |
0.6 | 4.3 | GO:0060539 | diaphragm development(GO:0060539) |
0.6 | 4.3 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.6 | 2.4 | GO:0046836 | glycolipid transport(GO:0046836) |
0.6 | 4.3 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.6 | 1.8 | GO:0010259 | multicellular organism aging(GO:0010259) |
0.6 | 3.0 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.6 | 6.7 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.6 | 10.9 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.6 | 1.8 | GO:1902287 | semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.6 | 0.6 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.6 | 16.9 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.6 | 31.9 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.6 | 1.2 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.6 | 6.6 | GO:0016073 | snRNA metabolic process(GO:0016073) |
0.6 | 0.6 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
0.6 | 2.4 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.6 | 0.6 | GO:0051818 | disruption of cells of other organism involved in symbiotic interaction(GO:0051818) killing of cells in other organism involved in symbiotic interaction(GO:0051883) |
0.6 | 13.0 | GO:0043488 | regulation of mRNA stability(GO:0043488) |
0.6 | 3.6 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.6 | 5.3 | GO:0009615 | response to virus(GO:0009615) |
0.6 | 2.3 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.6 | 2.3 | GO:0051298 | centrosome duplication(GO:0051298) |
0.6 | 1.2 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.6 | 4.1 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.6 | 1.7 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.6 | 0.6 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.6 | 0.6 | GO:0048102 | autophagic cell death(GO:0048102) |
0.6 | 6.4 | GO:0031929 | TOR signaling(GO:0031929) |
0.6 | 9.2 | GO:0070527 | platelet aggregation(GO:0070527) |
0.6 | 2.3 | GO:0061136 | regulation of proteasomal protein catabolic process(GO:0061136) |
0.6 | 2.3 | GO:0030220 | platelet formation(GO:0030220) |
0.6 | 136.7 | GO:0008380 | RNA splicing(GO:0008380) |
0.6 | 2.3 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.6 | 1.1 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.6 | 1.7 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.6 | 0.6 | GO:0001555 | oocyte growth(GO:0001555) regulation of progesterone secretion(GO:2000870) |
0.6 | 34.9 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.6 | 1.1 | GO:0021557 | oculomotor nerve development(GO:0021557) trochlear nerve development(GO:0021558) |
0.6 | 0.6 | GO:0019614 | catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
0.6 | 1.7 | GO:0072678 | T cell migration(GO:0072678) |
0.6 | 0.6 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) |
0.6 | 0.6 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.6 | 1.7 | GO:0090151 | establishment of protein localization to mitochondrial membrane(GO:0090151) |
0.6 | 14.4 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.6 | 0.6 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) |
0.6 | 5.0 | GO:0030168 | platelet activation(GO:0030168) |
0.6 | 2.2 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
0.5 | 5.5 | GO:0032481 | positive regulation of type I interferon production(GO:0032481) |
0.5 | 1.6 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.5 | 2.2 | GO:0031167 | rRNA methylation(GO:0031167) |
0.5 | 0.5 | GO:0034340 | response to type I interferon(GO:0034340) |
0.5 | 1.1 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.5 | 2.7 | GO:0009067 | aspartate family amino acid biosynthetic process(GO:0009067) |
0.5 | 1.6 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.5 | 0.5 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.5 | 3.2 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.5 | 0.5 | GO:0051446 | positive regulation of meiotic cell cycle(GO:0051446) |
0.5 | 0.5 | GO:0007418 | ventral midline development(GO:0007418) |
0.5 | 4.3 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.5 | 0.5 | GO:0060920 | cardiac pacemaker cell differentiation(GO:0060920) cardiac pacemaker cell development(GO:0060926) |
0.5 | 0.5 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.5 | 1.1 | GO:0071514 | genetic imprinting(GO:0071514) |
0.5 | 3.2 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.5 | 1.6 | GO:0003093 | regulation of glomerular filtration(GO:0003093) |
0.5 | 2.1 | GO:0010561 | negative regulation of glycoprotein biosynthetic process(GO:0010561) |
0.5 | 5.8 | GO:0031047 | gene silencing by RNA(GO:0031047) |
0.5 | 8.9 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
0.5 | 1.6 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.5 | 3.7 | GO:2000269 | regulation of fibroblast apoptotic process(GO:2000269) |
0.5 | 1.6 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.5 | 1.0 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.5 | 0.5 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.5 | 19.3 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.5 | 0.5 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
0.5 | 0.5 | GO:0016556 | mRNA modification(GO:0016556) |
0.5 | 50.2 | GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process(GO:0043161) |
0.5 | 0.5 | GO:0043032 | positive regulation of macrophage activation(GO:0043032) |
0.5 | 4.7 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
0.5 | 6.2 | GO:0006953 | acute-phase response(GO:0006953) |
0.5 | 1.0 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.5 | 1.5 | GO:0030149 | sphingolipid catabolic process(GO:0030149) |
0.5 | 1.0 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
0.5 | 20.5 | GO:0006413 | translational initiation(GO:0006413) |
0.5 | 0.5 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.5 | 8.7 | GO:0006672 | ceramide metabolic process(GO:0006672) |
0.5 | 1.0 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
0.5 | 0.5 | GO:0090467 | L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
0.5 | 3.0 | GO:0007051 | spindle organization(GO:0007051) |
0.5 | 19.8 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.5 | 0.5 | GO:2000316 | regulation of T-helper 17 type immune response(GO:2000316) |
0.5 | 3.0 | GO:0002437 | inflammatory response to antigenic stimulus(GO:0002437) |
0.5 | 1.5 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.5 | 2.5 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.5 | 10.1 | GO:0000070 | mitotic sister chromatid segregation(GO:0000070) |
0.5 | 2.0 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.5 | 0.5 | GO:2001138 | positive regulation of cellular respiration(GO:1901857) regulation of phospholipid transport(GO:2001138) positive regulation of phospholipid transport(GO:2001140) |
0.5 | 1.5 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.5 | 2.0 | GO:0033081 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.5 | 0.5 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.5 | 0.5 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.5 | 1.0 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.5 | 1.5 | GO:0048146 | positive regulation of fibroblast proliferation(GO:0048146) |
0.5 | 0.5 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
0.5 | 4.5 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
0.5 | 5.5 | GO:0006828 | manganese ion transport(GO:0006828) |
0.5 | 4.0 | GO:2001252 | positive regulation of chromosome organization(GO:2001252) |
0.5 | 3.5 | GO:0006525 | arginine metabolic process(GO:0006525) |
0.5 | 7.9 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.5 | 12.3 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.5 | 0.5 | GO:0071830 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.5 | 4.9 | GO:0042537 | benzene-containing compound metabolic process(GO:0042537) |
0.5 | 3.9 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.5 | 0.5 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.5 | 1.0 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.5 | 1.0 | GO:0042743 | hydrogen peroxide metabolic process(GO:0042743) |
0.5 | 7.8 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.5 | 0.5 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.5 | 0.5 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
0.5 | 0.5 | GO:0070988 | demethylation(GO:0070988) |
0.5 | 20.3 | GO:0006397 | mRNA processing(GO:0006397) |
0.5 | 0.5 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
0.5 | 0.5 | GO:0001774 | microglial cell activation(GO:0001774) |
0.5 | 3.3 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.5 | 1.0 | GO:0016045 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.5 | 0.9 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.5 | 0.5 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.5 | 3.3 | GO:0045682 | regulation of epidermis development(GO:0045682) |
0.5 | 1.4 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
0.5 | 0.5 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.5 | 0.5 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.5 | 2.8 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.5 | 1.9 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.5 | 0.5 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.5 | 2.3 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.5 | 0.5 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) |
0.5 | 0.5 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.5 | 0.9 | GO:0009249 | protein lipoylation(GO:0009249) |
0.5 | 3.2 | GO:0042407 | cristae formation(GO:0042407) |
0.5 | 8.7 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.5 | 1.8 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.5 | 1.4 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
0.5 | 0.5 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.5 | 0.9 | GO:0070613 | regulation of protein processing(GO:0070613) regulation of protein maturation(GO:1903317) |
0.5 | 0.9 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.5 | 0.9 | GO:0042891 | antibiotic transport(GO:0042891) |
0.4 | 1.8 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.4 | 2.2 | GO:0002548 | monocyte chemotaxis(GO:0002548) |
0.4 | 2.2 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.4 | 44.9 | GO:0006396 | RNA processing(GO:0006396) |
0.4 | 0.4 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.4 | 3.1 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.4 | 2.6 | GO:0000338 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.4 | 3.1 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.4 | 0.4 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.4 | 3.9 | GO:0001675 | acrosome assembly(GO:0001675) |
0.4 | 1.3 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.4 | 0.4 | GO:2000510 | positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.4 | 1.7 | GO:0006547 | histidine metabolic process(GO:0006547) |
0.4 | 0.4 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.4 | 4.7 | GO:0051028 | mRNA transport(GO:0051028) |
0.4 | 1.3 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.4 | 37.7 | GO:0032259 | methylation(GO:0032259) |
0.4 | 0.4 | GO:0033034 | positive regulation of myeloid cell apoptotic process(GO:0033034) |
0.4 | 0.8 | GO:1903427 | negative regulation of reactive oxygen species biosynthetic process(GO:1903427) |
0.4 | 1.3 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.4 | 1.7 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.4 | 2.1 | GO:0031297 | replication fork processing(GO:0031297) |
0.4 | 4.6 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.4 | 8.4 | GO:0009060 | aerobic respiration(GO:0009060) |
0.4 | 0.8 | GO:0098700 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.4 | 1.2 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.4 | 0.8 | GO:2000425 | regulation of apoptotic cell clearance(GO:2000425) |
0.4 | 2.1 | GO:0051168 | nuclear export(GO:0051168) |
0.4 | 7.0 | GO:0030042 | actin filament depolymerization(GO:0030042) |
0.4 | 0.4 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.4 | 0.4 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.4 | 1.2 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.4 | 2.5 | GO:1901660 | calcium ion export(GO:1901660) |
0.4 | 1.2 | GO:0006623 | protein targeting to vacuole(GO:0006623) |
0.4 | 0.4 | GO:0010984 | regulation of lipoprotein particle clearance(GO:0010984) |
0.4 | 0.8 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
0.4 | 2.0 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.4 | 5.7 | GO:0016575 | histone deacetylation(GO:0016575) |
0.4 | 0.8 | GO:0031076 | embryonic camera-type eye development(GO:0031076) |
0.4 | 7.7 | GO:0035383 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.4 | 2.0 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.4 | 2.4 | GO:2001239 | regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001239) |
0.4 | 1.6 | GO:2001223 | negative regulation of neuron migration(GO:2001223) |
0.4 | 1.2 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) positive regulation of axon guidance(GO:1902669) |
0.4 | 2.8 | GO:0072528 | pyrimidine-containing compound biosynthetic process(GO:0072528) |
0.4 | 3.6 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.4 | 1.2 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.4 | 3.2 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.4 | 0.8 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.4 | 3.6 | GO:0050729 | positive regulation of inflammatory response(GO:0050729) |
0.4 | 4.4 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.4 | 0.8 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
0.4 | 0.4 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.4 | 0.8 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.4 | 0.4 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.4 | 1.6 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.4 | 14.8 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.4 | 1.2 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
0.4 | 1.6 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
0.4 | 6.3 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.4 | 0.8 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.4 | 4.7 | GO:0006491 | N-glycan processing(GO:0006491) |
0.4 | 0.8 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.4 | 21.1 | GO:0006457 | protein folding(GO:0006457) |
0.4 | 0.8 | GO:0071801 | regulation of podosome assembly(GO:0071801) |
0.4 | 1.6 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.4 | 0.4 | GO:0072512 | ferric iron transport(GO:0015682) trivalent inorganic cation transport(GO:0072512) |
0.4 | 0.4 | GO:0050994 | regulation of lipid catabolic process(GO:0050994) |
0.4 | 2.3 | GO:1901983 | regulation of protein acetylation(GO:1901983) |
0.4 | 0.8 | GO:2000384 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.4 | 0.8 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.4 | 1.9 | GO:0043584 | nose development(GO:0043584) |
0.4 | 0.8 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.4 | 0.4 | GO:1901607 | alpha-amino acid biosynthetic process(GO:1901607) |
0.4 | 0.4 | GO:0000959 | mitochondrial RNA metabolic process(GO:0000959) |
0.4 | 1.5 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
0.4 | 1.9 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.4 | 3.4 | GO:0006465 | signal peptide processing(GO:0006465) |
0.4 | 0.4 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.4 | 2.6 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.4 | 0.4 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.4 | 1.5 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.4 | 1.9 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.4 | 0.7 | GO:0051177 | meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
0.4 | 0.4 | GO:0046865 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.4 | 0.7 | GO:0006405 | RNA export from nucleus(GO:0006405) |
0.4 | 4.1 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
0.4 | 1.9 | GO:2000378 | negative regulation of reactive oxygen species metabolic process(GO:2000378) |
0.4 | 0.4 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.4 | 1.1 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.4 | 0.4 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.4 | 4.4 | GO:0065002 | intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
0.4 | 2.2 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.4 | 0.4 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
0.4 | 1.1 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.4 | 3.3 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.4 | 3.7 | GO:0006805 | xenobiotic metabolic process(GO:0006805) |
0.4 | 3.7 | GO:0071427 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
0.4 | 0.7 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.4 | 0.7 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.4 | 1.1 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.4 | 0.4 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.4 | 0.4 | GO:0035822 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
0.4 | 0.7 | GO:1990874 | regulation of vascular smooth muscle cell proliferation(GO:1904705) positive regulation of vascular smooth muscle cell proliferation(GO:1904707) vascular smooth muscle cell proliferation(GO:1990874) |
0.4 | 1.1 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.4 | 0.7 | GO:0042501 | serine phosphorylation of STAT3 protein(GO:0033136) serine phosphorylation of STAT protein(GO:0042501) |
0.4 | 0.7 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.4 | 1.4 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
0.4 | 0.4 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.4 | 1.1 | GO:0007512 | adult heart development(GO:0007512) |
0.4 | 6.1 | GO:0071347 | cellular response to interleukin-1(GO:0071347) |
0.4 | 0.4 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.4 | 0.4 | GO:0007567 | parturition(GO:0007567) |
0.4 | 0.4 | GO:0019042 | viral latency(GO:0019042) |
0.4 | 1.4 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.4 | 0.7 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
0.4 | 1.8 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.4 | 1.1 | GO:0046605 | regulation of centrosome cycle(GO:0046605) |
0.4 | 0.7 | GO:0090181 | regulation of cholesterol metabolic process(GO:0090181) |
0.3 | 0.7 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) |
0.3 | 4.2 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
0.3 | 0.7 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.3 | 2.1 | GO:0046549 | retinal cone cell development(GO:0046549) |
0.3 | 1.0 | GO:0002279 | mast cell activation involved in immune response(GO:0002279) mast cell mediated immunity(GO:0002448) mast cell degranulation(GO:0043303) |
0.3 | 0.3 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
0.3 | 0.7 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.3 | 2.4 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.3 | 7.2 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.3 | 0.3 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.3 | 0.3 | GO:1901796 | regulation of signal transduction by p53 class mediator(GO:1901796) |
0.3 | 1.4 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.3 | 2.4 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.3 | 2.1 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.3 | 0.7 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.3 | 3.8 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.3 | 0.7 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.3 | 0.3 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.3 | 4.1 | GO:0010842 | retina layer formation(GO:0010842) |
0.3 | 5.1 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.3 | 0.7 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.3 | 1.0 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.3 | 87.1 | GO:0006412 | translation(GO:0006412) |
0.3 | 0.3 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) |
0.3 | 2.4 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.3 | 2.4 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.3 | 0.3 | GO:0015865 | purine nucleotide transport(GO:0015865) purine ribonucleotide transport(GO:0015868) |
0.3 | 1.0 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.3 | 3.4 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.3 | 0.3 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.3 | 0.3 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.3 | 2.3 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.3 | 2.7 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.3 | 1.3 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.3 | 0.3 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.3 | 4.3 | GO:0008630 | intrinsic apoptotic signaling pathway in response to DNA damage(GO:0008630) |
0.3 | 2.0 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.3 | 10.6 | GO:0006970 | response to osmotic stress(GO:0006970) |
0.3 | 0.7 | GO:0070897 | DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
0.3 | 0.3 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.3 | 0.7 | GO:0002155 | regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
0.3 | 2.3 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.3 | 1.0 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
0.3 | 0.3 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.3 | 0.3 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.3 | 0.7 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.3 | 1.0 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
0.3 | 0.6 | GO:0042345 | regulation of NF-kappaB import into nucleus(GO:0042345) NF-kappaB import into nucleus(GO:0042348) |
0.3 | 1.0 | GO:0006734 | NADH metabolic process(GO:0006734) |
0.3 | 10.0 | GO:0009636 | response to toxic substance(GO:0009636) |
0.3 | 0.3 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.3 | 0.6 | GO:0051782 | negative regulation of cell division(GO:0051782) |
0.3 | 1.9 | GO:0032098 | regulation of appetite(GO:0032098) |
0.3 | 1.6 | GO:0007127 | meiosis I(GO:0007127) |
0.3 | 1.9 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
0.3 | 10.8 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.3 | 25.8 | GO:0051607 | defense response to virus(GO:0051607) |
0.3 | 4.1 | GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0006919) |
0.3 | 5.1 | GO:0009268 | response to pH(GO:0009268) |
0.3 | 0.6 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.3 | 1.3 | GO:0044773 | mitotic DNA damage checkpoint(GO:0044773) |
0.3 | 1.3 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.3 | 0.3 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.3 | 4.7 | GO:0042035 | regulation of cytokine biosynthetic process(GO:0042035) |
0.3 | 4.1 | GO:0019835 | cytolysis(GO:0019835) |
0.3 | 0.3 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.3 | 0.3 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.3 | 5.0 | GO:0022900 | electron transport chain(GO:0022900) |
0.3 | 0.3 | GO:0060526 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.3 | 1.5 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.3 | 5.5 | GO:0060324 | face development(GO:0060324) |
0.3 | 0.3 | GO:0046466 | membrane lipid catabolic process(GO:0046466) |
0.3 | 1.8 | GO:0048844 | artery morphogenesis(GO:0048844) |
0.3 | 0.9 | GO:0002760 | positive regulation of antimicrobial humoral response(GO:0002760) |
0.3 | 0.6 | GO:0070163 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) negative regulation of adiponectin secretion(GO:0070164) |
0.3 | 0.9 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.3 | 0.3 | GO:0061365 | positive regulation of triglyceride lipase activity(GO:0061365) |
0.3 | 0.6 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.3 | 0.3 | GO:0010523 | negative regulation of calcium ion transport into cytosol(GO:0010523) |
0.3 | 0.6 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.3 | 0.6 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.3 | 93.0 | GO:0055114 | oxidation-reduction process(GO:0055114) |
0.3 | 1.2 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.3 | 0.3 | GO:0090237 | regulation of arachidonic acid secretion(GO:0090237) |
0.3 | 0.3 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.3 | 1.5 | GO:0030878 | thyroid gland development(GO:0030878) |
0.3 | 2.0 | GO:0001945 | lymph vessel development(GO:0001945) |
0.3 | 2.0 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.3 | 0.9 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.3 | 0.3 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.3 | 0.3 | GO:0019086 | late viral transcription(GO:0019086) |
0.3 | 0.6 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.3 | 1.2 | GO:0042246 | tissue regeneration(GO:0042246) |
0.3 | 0.6 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.3 | 0.6 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.3 | 2.3 | GO:0002381 | immunoglobulin production involved in immunoglobulin mediated immune response(GO:0002381) |
0.3 | 0.9 | GO:2000738 | positive regulation of stem cell differentiation(GO:2000738) |
0.3 | 2.0 | GO:0031103 | axon regeneration(GO:0031103) |
0.3 | 0.3 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.3 | 0.3 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
0.3 | 0.5 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.3 | 1.1 | GO:1904030 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.3 | 0.3 | GO:0032648 | regulation of interferon-beta production(GO:0032648) |
0.3 | 1.9 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.3 | 0.3 | GO:0031639 | plasminogen activation(GO:0031639) |
0.3 | 1.9 | GO:1904376 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.3 | 0.3 | GO:0009650 | UV protection(GO:0009650) |
0.3 | 2.9 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.3 | 2.4 | GO:0002687 | positive regulation of leukocyte migration(GO:0002687) |
0.3 | 0.8 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.3 | 3.4 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) regulation of cyclin-dependent protein kinase activity(GO:1904029) |
0.3 | 0.3 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.3 | 0.5 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.3 | 0.3 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
0.3 | 0.3 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.3 | 1.8 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
0.3 | 1.3 | GO:0097345 | mitochondrial outer membrane permeabilization(GO:0097345) |
0.3 | 0.8 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.2 | 0.2 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.2 | 0.7 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.2 | 0.5 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.2 | 1.0 | GO:0045116 | protein neddylation(GO:0045116) |
0.2 | 0.5 | GO:0051324 | meiotic prophase I(GO:0007128) prophase(GO:0051324) meiotic cell cycle phase(GO:0098762) meiosis I cell cycle phase(GO:0098764) |
0.2 | 0.2 | GO:0001714 | endodermal cell fate specification(GO:0001714) |
0.2 | 0.7 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
0.2 | 5.3 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.2 | 0.5 | GO:0035865 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.2 | 0.7 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.2 | 1.2 | GO:0006220 | pyrimidine nucleotide metabolic process(GO:0006220) |
0.2 | 5.0 | GO:0015991 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.2 | 0.9 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.2 | 3.0 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.2 | 0.7 | GO:0015858 | nucleoside transport(GO:0015858) |
0.2 | 0.2 | GO:0001893 | maternal placenta development(GO:0001893) |
0.2 | 0.5 | GO:0009988 | cell-cell recognition(GO:0009988) |
0.2 | 0.9 | GO:0015074 | DNA integration(GO:0015074) |
0.2 | 0.7 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.2 | 0.2 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.2 | 0.9 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.2 | 0.9 | GO:0033013 | tetrapyrrole metabolic process(GO:0033013) |
0.2 | 0.4 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.2 | 2.5 | GO:0016573 | histone acetylation(GO:0016573) |
0.2 | 2.7 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.2 | 0.2 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.2 | 0.2 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.2 | 0.4 | GO:0090068 | positive regulation of cell cycle process(GO:0090068) |
0.2 | 0.7 | GO:0070266 | necroptotic process(GO:0070266) |
0.2 | 0.2 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.2 | 0.2 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.2 | 3.0 | GO:0030279 | negative regulation of ossification(GO:0030279) |
0.2 | 1.5 | GO:0042255 | ribosome assembly(GO:0042255) |
0.2 | 1.1 | GO:0014003 | oligodendrocyte development(GO:0014003) |
0.2 | 1.3 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.2 | 0.2 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.2 | 0.4 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.2 | 0.4 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.2 | 2.1 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.2 | 0.8 | GO:0044246 | regulation of collagen metabolic process(GO:0010712) regulation of multicellular organismal metabolic process(GO:0044246) |
0.2 | 0.2 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.2 | 0.8 | GO:0007584 | response to nutrient(GO:0007584) |
0.2 | 1.0 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.2 | 10.1 | GO:0070482 | response to oxygen levels(GO:0070482) |
0.2 | 0.2 | GO:0090594 | wound healing involved in inflammatory response(GO:0002246) inflammatory response to wounding(GO:0090594) |
0.2 | 1.6 | GO:0051099 | positive regulation of binding(GO:0051099) |
0.2 | 0.4 | GO:0002820 | negative regulation of adaptive immune response(GO:0002820) |
0.2 | 0.2 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
0.2 | 0.4 | GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
0.2 | 17.7 | GO:0007067 | mitotic nuclear division(GO:0007067) |
0.2 | 0.6 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.2 | 0.4 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.2 | 3.4 | GO:0003281 | ventricular septum development(GO:0003281) |
0.2 | 0.2 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.2 | 0.6 | GO:0051297 | centrosome organization(GO:0051297) |
0.2 | 0.4 | GO:0018393 | internal peptidyl-lysine acetylation(GO:0018393) |
0.2 | 18.0 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.2 | 1.4 | GO:0006641 | triglyceride metabolic process(GO:0006641) |
0.2 | 0.2 | GO:0050798 | activated T cell proliferation(GO:0050798) |
0.2 | 0.4 | GO:0045297 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
0.2 | 0.2 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.2 | 5.0 | GO:0007599 | hemostasis(GO:0007599) |
0.2 | 0.2 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.2 | 4.0 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.2 | 0.2 | GO:0060914 | heart formation(GO:0060914) |
0.2 | 0.9 | GO:0002579 | positive regulation of antigen processing and presentation(GO:0002579) |
0.2 | 6.4 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
0.2 | 0.2 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.2 | 0.2 | GO:0097006 | regulation of plasma lipoprotein particle levels(GO:0097006) |
0.2 | 0.9 | GO:0014044 | Schwann cell development(GO:0014044) |
0.2 | 0.4 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.2 | 0.2 | GO:0033108 | mitochondrial respiratory chain complex assembly(GO:0033108) |
0.2 | 0.9 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.2 | 0.4 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.2 | 7.0 | GO:0006310 | DNA recombination(GO:0006310) |
0.2 | 0.9 | GO:0097009 | energy homeostasis(GO:0097009) |
0.2 | 0.2 | GO:0032898 | neurotrophin production(GO:0032898) |
0.2 | 1.7 | GO:0071594 | T cell differentiation in thymus(GO:0033077) thymocyte aggregation(GO:0071594) |
0.2 | 0.3 | GO:0048144 | fibroblast proliferation(GO:0048144) |
0.2 | 1.2 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.2 | 0.2 | GO:0010841 | positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) |
0.2 | 0.2 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.2 | 1.3 | GO:0098739 | import across plasma membrane(GO:0098739) |
0.2 | 0.2 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.2 | 1.1 | GO:0016926 | protein desumoylation(GO:0016926) |
0.2 | 0.2 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.2 | 0.2 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
0.2 | 0.2 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.2 | 0.6 | GO:0021983 | pituitary gland development(GO:0021983) |
0.2 | 0.9 | GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway(GO:2001243) |
0.2 | 0.2 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.2 | 0.3 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.2 | 1.1 | GO:0022410 | circadian sleep/wake cycle process(GO:0022410) |
0.2 | 0.2 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.1 | 0.1 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.1 | 0.1 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.1 | 2.5 | GO:0051289 | protein homotetramerization(GO:0051289) |
0.1 | 0.1 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.1 | 5.2 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.1 | 0.3 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
0.1 | 1.4 | GO:0006959 | humoral immune response(GO:0006959) |
0.1 | 0.4 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.1 | 0.1 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.1 | 0.1 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.1 | 145.5 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.1 | 0.9 | GO:0034033 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.1 | 0.1 | GO:0032677 | regulation of interleukin-8 production(GO:0032677) |
0.1 | 0.8 | GO:0006477 | protein sulfation(GO:0006477) |
0.1 | 0.1 | GO:0019217 | regulation of fatty acid metabolic process(GO:0019217) |
0.1 | 0.1 | GO:0010498 | proteasomal protein catabolic process(GO:0010498) |
0.1 | 0.5 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.1 | 4.4 | GO:0030278 | regulation of ossification(GO:0030278) |
0.1 | 0.2 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.1 | 0.1 | GO:0060022 | hard palate development(GO:0060022) |
0.1 | 0.1 | GO:0002551 | mast cell chemotaxis(GO:0002551) |
0.1 | 0.2 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.1 | 0.1 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.1 | 0.2 | GO:1901017 | negative regulation of potassium ion transmembrane transporter activity(GO:1901017) |
0.1 | 0.1 | GO:0008355 | olfactory learning(GO:0008355) |
0.1 | 0.1 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.1 | 1.4 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.1 | 0.1 | GO:0035305 | negative regulation of dephosphorylation(GO:0035305) |
0.1 | 0.1 | GO:0060433 | bronchus development(GO:0060433) lobar bronchus epithelium development(GO:0060481) |
0.1 | 0.4 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.1 | 0.1 | GO:0051350 | negative regulation of adenylate cyclase activity(GO:0007194) negative regulation of cyclase activity(GO:0031280) negative regulation of lyase activity(GO:0051350) |
0.1 | 0.2 | GO:0014820 | tonic smooth muscle contraction(GO:0014820) |
0.1 | 0.8 | GO:0006352 | DNA-templated transcription, initiation(GO:0006352) |
0.1 | 0.1 | GO:0006399 | tRNA metabolic process(GO:0006399) |
0.1 | 0.2 | GO:0001556 | oocyte maturation(GO:0001556) |
0.1 | 0.4 | GO:0060487 | lung cell differentiation(GO:0060479) lung epithelial cell differentiation(GO:0060487) |
0.1 | 0.8 | GO:0044804 | nucleophagy(GO:0044804) |
0.1 | 0.1 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.1 | 0.4 | GO:0003323 | type B pancreatic cell development(GO:0003323) |
0.1 | 0.3 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.1 | 0.1 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.1 | 0.3 | GO:2000737 | negative regulation of stem cell differentiation(GO:2000737) |
0.1 | 0.1 | GO:0002042 | cell migration involved in sprouting angiogenesis(GO:0002042) |
0.1 | 0.1 | GO:0032675 | regulation of interleukin-6 production(GO:0032675) |
0.1 | 0.1 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.1 | 0.3 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.1 | 0.1 | GO:0008216 | spermidine metabolic process(GO:0008216) |
0.1 | 6.5 | GO:0098542 | defense response to other organism(GO:0098542) |
0.1 | 9.3 | GO:0019236 | response to pheromone(GO:0019236) |
0.1 | 0.1 | GO:0000096 | sulfur amino acid metabolic process(GO:0000096) |
0.1 | 0.3 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.1 | 0.1 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.1 | 0.1 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.1 | 0.2 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.1 | 0.1 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.1 | 0.3 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 0.3 | GO:1901264 | carbohydrate derivative transport(GO:1901264) |
0.1 | 1.3 | GO:0007030 | Golgi organization(GO:0007030) |
0.1 | 0.1 | GO:0034101 | erythrocyte homeostasis(GO:0034101) |
0.1 | 0.2 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.1 | 0.1 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.1 | 0.5 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.1 | 0.2 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.1 | 0.2 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.1 | 0.1 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.1 | 0.2 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.1 | 0.1 | GO:0071800 | podosome assembly(GO:0071800) |
0.1 | 0.1 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.1 | 0.6 | GO:0030183 | B cell differentiation(GO:0030183) |
0.1 | 0.1 | GO:0003383 | apical constriction(GO:0003383) |
0.1 | 1.7 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.1 | 0.1 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.1 | 0.1 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.1 | 0.1 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.1 | 0.1 | GO:0046909 | intermembrane transport(GO:0046909) |
0.1 | 0.1 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.1 | 0.1 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
0.1 | 0.4 | GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin(GO:0003081) |
0.1 | 0.1 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.1 | 0.6 | GO:0072348 | sulfur compound transport(GO:0072348) |
0.1 | 1.1 | GO:0051321 | meiotic cell cycle(GO:0051321) |
0.1 | 0.3 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.1 | 1.2 | GO:0019935 | cyclic-nucleotide-mediated signaling(GO:0019935) |
0.1 | 0.2 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.1 | 0.1 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.1 | 0.1 | GO:0006266 | DNA ligation(GO:0006266) |
0.1 | 0.1 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.1 | 0.1 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.1 | 0.4 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.1 | 0.1 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.1 | 2.2 | GO:0006260 | DNA replication(GO:0006260) |
0.1 | 0.1 | GO:0014029 | neural crest formation(GO:0014029) |
0.0 | 0.0 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.0 | 0.0 | GO:0072538 | T-helper 17 type immune response(GO:0072538) |
0.0 | 0.1 | GO:0015800 | acidic amino acid transport(GO:0015800) |
0.0 | 0.0 | GO:0070168 | negative regulation of biomineral tissue development(GO:0070168) |
0.0 | 0.0 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.0 | 0.0 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.0 | 0.0 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.0 | 0.0 | GO:0001990 | regulation of systemic arterial blood pressure by hormone(GO:0001990) |
0.0 | 0.1 | GO:0048599 | oocyte development(GO:0048599) |
0.0 | 0.1 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.0 | 0.0 | GO:0009620 | response to fungus(GO:0009620) |
0.0 | 0.0 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.0 | 0.3 | GO:0009201 | ribonucleoside triphosphate biosynthetic process(GO:0009201) |
0.0 | 0.0 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.0 | 0.1 | GO:0070459 | prolactin secretion(GO:0070459) |
0.0 | 0.0 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.0 | 0.0 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.0 | 0.0 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.0 | 0.0 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.0 | 0.0 | GO:0090494 | catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
0.0 | 0.0 | GO:1903367 | positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
0.0 | 0.2 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.0 | 0.0 | GO:0002251 | organ or tissue specific immune response(GO:0002251) |
0.0 | 0.7 | GO:0016485 | protein processing(GO:0016485) |
0.0 | 0.2 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.0 | 0.0 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.0 | 0.0 | GO:0006304 | DNA modification(GO:0006304) |
0.0 | 0.0 | GO:1901374 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.0 | 0.0 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.0 | 0.0 | GO:0032225 | regulation of synaptic transmission, dopaminergic(GO:0032225) |
0.0 | 0.0 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.0 | 0.0 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.0 | 0.0 | GO:0015808 | L-alanine transport(GO:0015808) |
0.0 | 0.0 | GO:0060179 | male mating behavior(GO:0060179) |
0.0 | 0.0 | GO:0070305 | response to cGMP(GO:0070305) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
17.4 | 69.7 | GO:0032437 | cuticular plate(GO:0032437) |
14.2 | 42.5 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
12.7 | 38.1 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
10.1 | 70.7 | GO:0005833 | hemoglobin complex(GO:0005833) |
10.0 | 40.1 | GO:0042583 | chromaffin granule(GO:0042583) |
8.6 | 17.1 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
8.0 | 32.0 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
6.9 | 62.4 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
6.9 | 41.3 | GO:1990462 | omegasome(GO:1990462) |
6.6 | 85.5 | GO:0036038 | MKS complex(GO:0036038) |
6.3 | 25.3 | GO:0030127 | COPII vesicle coat(GO:0030127) |
6.2 | 18.5 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
6.0 | 47.9 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
6.0 | 23.9 | GO:1990130 | Iml1 complex(GO:1990130) |
5.9 | 23.6 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
5.6 | 16.8 | GO:0008091 | spectrin(GO:0008091) |
5.4 | 21.6 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
4.9 | 39.3 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
4.7 | 23.6 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
4.3 | 12.9 | GO:0031094 | platelet dense tubular network(GO:0031094) |
4.2 | 16.7 | GO:0005642 | annulate lamellae(GO:0005642) |
4.1 | 12.2 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
3.7 | 36.8 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
3.6 | 10.8 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
3.6 | 17.8 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
3.5 | 10.6 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
3.4 | 10.3 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
3.4 | 20.4 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
3.4 | 13.6 | GO:0098536 | deuterosome(GO:0098536) |
3.3 | 40.1 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
3.3 | 9.9 | GO:0097413 | Lewy body(GO:0097413) |
3.2 | 6.4 | GO:0032587 | ruffle membrane(GO:0032587) |
3.2 | 9.5 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
3.1 | 21.5 | GO:0005775 | vacuolar lumen(GO:0005775) |
3.0 | 21.3 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
3.0 | 8.9 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
2.9 | 11.8 | GO:0097524 | sperm plasma membrane(GO:0097524) |
2.9 | 8.8 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
2.9 | 11.6 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
2.8 | 8.4 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
2.8 | 33.3 | GO:0005652 | nuclear lamina(GO:0005652) |
2.8 | 8.3 | GO:0005899 | insulin receptor complex(GO:0005899) |
2.7 | 22.0 | GO:0032591 | dendritic spine membrane(GO:0032591) |
2.7 | 8.2 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
2.7 | 13.5 | GO:0000235 | astral microtubule(GO:0000235) |
2.7 | 21.3 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
2.6 | 7.9 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
2.5 | 35.6 | GO:0042589 | zymogen granule membrane(GO:0042589) |
2.5 | 2.5 | GO:1990423 | RZZ complex(GO:1990423) |
2.5 | 15.1 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
2.5 | 10.1 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
2.5 | 10.0 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
2.5 | 7.4 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
2.5 | 7.4 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
2.4 | 12.1 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
2.4 | 9.7 | GO:0030315 | T-tubule(GO:0030315) |
2.4 | 9.7 | GO:0097452 | GAIT complex(GO:0097452) |
2.4 | 12.0 | GO:0033093 | Weibel-Palade body(GO:0033093) |
2.4 | 2.4 | GO:0031143 | pseudopodium(GO:0031143) |
2.4 | 4.7 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
2.3 | 7.0 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
2.3 | 16.4 | GO:0033263 | CORVET complex(GO:0033263) |
2.3 | 20.9 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
2.3 | 9.3 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
2.3 | 138.5 | GO:0000118 | histone deacetylase complex(GO:0000118) |
2.3 | 32.2 | GO:0035869 | ciliary transition zone(GO:0035869) |
2.3 | 41.4 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
2.3 | 16.0 | GO:0031931 | TORC1 complex(GO:0031931) |
2.3 | 9.1 | GO:0005677 | chromatin silencing complex(GO:0005677) |
2.3 | 34.1 | GO:0000421 | autophagosome membrane(GO:0000421) |
2.3 | 11.4 | GO:0005827 | polar microtubule(GO:0005827) |
2.3 | 11.3 | GO:0016461 | unconventional myosin complex(GO:0016461) |
2.2 | 6.7 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
2.2 | 15.5 | GO:1990204 | oxidoreductase complex(GO:1990204) |
2.2 | 22.0 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
2.2 | 15.3 | GO:0031083 | BLOC-1 complex(GO:0031083) |
2.2 | 171.6 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
2.2 | 21.7 | GO:0097539 | ciliary transition fiber(GO:0097539) |
2.2 | 12.9 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
2.1 | 45.0 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
2.1 | 32.1 | GO:0002102 | podosome(GO:0002102) |
2.1 | 19.2 | GO:0005869 | dynactin complex(GO:0005869) |
2.1 | 21.0 | GO:0042581 | specific granule(GO:0042581) |
2.1 | 8.4 | GO:0045298 | tubulin complex(GO:0045298) |
2.1 | 14.6 | GO:0044232 | organelle membrane contact site(GO:0044232) |
2.1 | 2.1 | GO:0030897 | HOPS complex(GO:0030897) |
2.1 | 14.4 | GO:0043203 | axon hillock(GO:0043203) |
2.0 | 9.9 | GO:0042382 | paraspeckles(GO:0042382) |
2.0 | 7.9 | GO:0044294 | dendritic growth cone(GO:0044294) |
1.9 | 5.8 | GO:0071565 | nBAF complex(GO:0071565) |
1.9 | 13.6 | GO:0060091 | kinocilium(GO:0060091) |
1.9 | 24.6 | GO:0030914 | STAGA complex(GO:0030914) |
1.9 | 7.5 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
1.9 | 7.5 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
1.9 | 13.2 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
1.9 | 5.6 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
1.9 | 9.3 | GO:0005927 | muscle tendon junction(GO:0005927) |
1.8 | 23.9 | GO:1904949 | ATPase complex(GO:1904949) |
1.8 | 14.7 | GO:0051286 | cell tip(GO:0051286) |
1.8 | 10.9 | GO:0042629 | mast cell granule(GO:0042629) |
1.8 | 3.6 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
1.8 | 5.4 | GO:0032797 | SMN complex(GO:0032797) |
1.8 | 9.0 | GO:0071438 | invadopodium membrane(GO:0071438) |
1.8 | 54.6 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
1.8 | 5.3 | GO:0043293 | apoptosome(GO:0043293) |
1.7 | 8.7 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
1.7 | 13.9 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
1.7 | 6.8 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
1.7 | 8.5 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
1.7 | 6.8 | GO:0016589 | NURF complex(GO:0016589) |
1.7 | 16.7 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
1.6 | 22.8 | GO:0001741 | XY body(GO:0001741) |
1.6 | 3.2 | GO:0032010 | phagolysosome(GO:0032010) |
1.6 | 14.5 | GO:0046581 | intercellular canaliculus(GO:0046581) |
1.6 | 8.0 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
1.6 | 3.2 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
1.6 | 12.7 | GO:0035631 | CD40 receptor complex(GO:0035631) |
1.6 | 4.7 | GO:0005745 | m-AAA complex(GO:0005745) |
1.6 | 68.5 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
1.6 | 9.3 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
1.5 | 9.2 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
1.5 | 114.3 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
1.5 | 6.1 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
1.5 | 3.0 | GO:0043219 | lateral loop(GO:0043219) |
1.5 | 7.5 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
1.5 | 1.5 | GO:0000439 | core TFIIH complex(GO:0000439) |
1.5 | 4.4 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
1.5 | 41.4 | GO:0016592 | mediator complex(GO:0016592) |
1.5 | 13.3 | GO:0000815 | ESCRT III complex(GO:0000815) |
1.5 | 5.9 | GO:0005828 | kinetochore microtubule(GO:0005828) |
1.5 | 5.8 | GO:0032389 | MutLalpha complex(GO:0032389) |
1.5 | 5.8 | GO:0098576 | lumenal side of membrane(GO:0098576) |
1.5 | 146.7 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
1.4 | 60.6 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
1.4 | 72.1 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
1.4 | 1.4 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
1.4 | 21.6 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
1.4 | 54.5 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
1.4 | 1.4 | GO:0036396 | MIS complex(GO:0036396) |
1.4 | 8.3 | GO:0035859 | Seh1-associated complex(GO:0035859) |
1.4 | 1.4 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
1.4 | 4.1 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
1.4 | 15.0 | GO:0031616 | spindle pole centrosome(GO:0031616) |
1.4 | 1.4 | GO:0016939 | kinesin II complex(GO:0016939) |
1.4 | 1.4 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
1.4 | 5.4 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
1.4 | 8.1 | GO:0031415 | NatA complex(GO:0031415) |
1.3 | 8.1 | GO:0044292 | dendrite terminus(GO:0044292) |
1.3 | 5.3 | GO:0038201 | TOR complex(GO:0038201) |
1.3 | 4.0 | GO:0046691 | intracellular canaliculus(GO:0046691) |
1.3 | 5.3 | GO:0090543 | Flemming body(GO:0090543) |
1.3 | 5.3 | GO:0005903 | brush border(GO:0005903) |
1.3 | 4.0 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
1.3 | 13.2 | GO:0031512 | motile primary cilium(GO:0031512) |
1.3 | 7.9 | GO:0071986 | Ragulator complex(GO:0071986) |
1.3 | 5.2 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
1.3 | 14.2 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
1.3 | 3.9 | GO:0000805 | X chromosome(GO:0000805) |
1.3 | 28.4 | GO:0055038 | recycling endosome membrane(GO:0055038) |
1.3 | 24.5 | GO:0034451 | centriolar satellite(GO:0034451) |
1.3 | 33.5 | GO:0012505 | endomembrane system(GO:0012505) |
1.3 | 7.7 | GO:0016600 | flotillin complex(GO:0016600) |
1.3 | 21.8 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
1.3 | 48.2 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
1.3 | 2.5 | GO:0044316 | cone cell pedicle(GO:0044316) |
1.2 | 3.7 | GO:0019815 | B cell receptor complex(GO:0019815) |
1.2 | 3.7 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
1.2 | 5.0 | GO:0071439 | clathrin complex(GO:0071439) |
1.2 | 2.5 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
1.2 | 7.4 | GO:0034464 | BBSome(GO:0034464) |
1.2 | 8.6 | GO:0072687 | meiotic spindle(GO:0072687) |
1.2 | 3.7 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
1.2 | 3.7 | GO:0097512 | cardiac myofibril(GO:0097512) |
1.2 | 4.9 | GO:0000938 | GARP complex(GO:0000938) |
1.2 | 10.9 | GO:0000813 | ESCRT I complex(GO:0000813) |
1.2 | 22.9 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
1.2 | 10.8 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
1.2 | 55.4 | GO:0005643 | nuclear pore(GO:0005643) |
1.2 | 1.2 | GO:0097208 | alveolar lamellar body(GO:0097208) |
1.2 | 7.2 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
1.2 | 11.9 | GO:0043196 | varicosity(GO:0043196) |
1.2 | 3.6 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
1.2 | 15.4 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
1.2 | 4.7 | GO:0031010 | ISWI-type complex(GO:0031010) |
1.2 | 2.4 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
1.2 | 10.5 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
1.2 | 12.8 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
1.2 | 3.5 | GO:0033269 | internode region of axon(GO:0033269) |
1.2 | 11.6 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
1.1 | 8.0 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
1.1 | 5.7 | GO:0030894 | replisome(GO:0030894) |
1.1 | 5.7 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
1.1 | 2.3 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
1.1 | 19.3 | GO:0016235 | aggresome(GO:0016235) |
1.1 | 85.3 | GO:0010008 | endosome membrane(GO:0010008) |
1.1 | 7.9 | GO:0046930 | pore complex(GO:0046930) |
1.1 | 7.8 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
1.1 | 15.5 | GO:0031985 | Golgi cisterna(GO:0031985) |
1.1 | 10.9 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
1.1 | 3.2 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
1.1 | 3.2 | GO:0000811 | GINS complex(GO:0000811) |
1.1 | 23.4 | GO:0005844 | polysome(GO:0005844) |
1.1 | 22.3 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
1.1 | 9.5 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
1.1 | 21.0 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
1.0 | 31.4 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
1.0 | 5.2 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
1.0 | 2.1 | GO:0036449 | microtubule minus-end(GO:0036449) |
1.0 | 3.1 | GO:0097450 | astrocyte end-foot(GO:0097450) |
1.0 | 5.2 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
1.0 | 49.6 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
1.0 | 11.3 | GO:0032039 | integrator complex(GO:0032039) |
1.0 | 3.1 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
1.0 | 5.0 | GO:0001940 | male pronucleus(GO:0001940) |
1.0 | 3.0 | GO:0042825 | TAP complex(GO:0042825) |
1.0 | 3.0 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
1.0 | 42.0 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
1.0 | 8.0 | GO:0045120 | pronucleus(GO:0045120) |
1.0 | 32.7 | GO:0031201 | SNARE complex(GO:0031201) |
1.0 | 3.0 | GO:0061574 | ASAP complex(GO:0061574) |
1.0 | 53.0 | GO:0005769 | early endosome(GO:0005769) |
1.0 | 2.9 | GO:0005858 | axonemal dynein complex(GO:0005858) |
1.0 | 4.9 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
1.0 | 23.2 | GO:0045335 | phagocytic vesicle(GO:0045335) |
1.0 | 1.0 | GO:0005884 | actin filament(GO:0005884) |
1.0 | 41.1 | GO:0005811 | lipid particle(GO:0005811) |
0.9 | 158.4 | GO:0016604 | nuclear body(GO:0016604) |
0.9 | 17.9 | GO:0005876 | spindle microtubule(GO:0005876) |
0.9 | 10.3 | GO:0031941 | filamentous actin(GO:0031941) |
0.9 | 16.9 | GO:0005776 | autophagosome(GO:0005776) |
0.9 | 30.0 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.9 | 3.7 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.9 | 8.4 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.9 | 142.9 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.9 | 4.7 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.9 | 3.7 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.9 | 0.9 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.9 | 2.8 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.9 | 4.6 | GO:0032433 | filopodium tip(GO:0032433) |
0.9 | 12.8 | GO:0015629 | actin cytoskeleton(GO:0015629) |
0.9 | 1.8 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.9 | 3.6 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.9 | 3.6 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.9 | 35.1 | GO:0000502 | proteasome complex(GO:0000502) |
0.9 | 34.2 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.9 | 8.1 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.9 | 9.8 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.9 | 2.7 | GO:0097422 | tubular endosome(GO:0097422) |
0.9 | 42.7 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.9 | 0.9 | GO:0070069 | cytochrome complex(GO:0070069) |
0.9 | 33.7 | GO:0015935 | small ribosomal subunit(GO:0015935) |
0.9 | 157.4 | GO:0005635 | nuclear envelope(GO:0005635) |
0.9 | 3.5 | GO:0098791 | Golgi stack(GO:0005795) Golgi subcompartment(GO:0098791) |
0.9 | 0.9 | GO:0005683 | U7 snRNP(GO:0005683) |
0.9 | 45.3 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.9 | 69.9 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.9 | 1.7 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.9 | 1.7 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.9 | 13.7 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.9 | 4.3 | GO:0061617 | MICOS complex(GO:0061617) |
0.9 | 5.1 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.9 | 4.3 | GO:0016363 | nuclear matrix(GO:0016363) |
0.9 | 6.0 | GO:0032426 | stereocilium tip(GO:0032426) |
0.9 | 0.9 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.8 | 929.5 | GO:0005739 | mitochondrion(GO:0005739) |
0.8 | 4.2 | GO:0032155 | cell division site(GO:0032153) cell division site part(GO:0032155) |
0.8 | 18.5 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.8 | 4.2 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.8 | 3.4 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.8 | 2.5 | GO:0097255 | R2TP complex(GO:0097255) |
0.8 | 4.2 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.8 | 12.4 | GO:0005771 | multivesicular body(GO:0005771) |
0.8 | 24.0 | GO:0005901 | caveola(GO:0005901) |
0.8 | 4.1 | GO:0044440 | endosomal part(GO:0044440) |
0.8 | 3.3 | GO:0002177 | manchette(GO:0002177) |
0.8 | 1.6 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.8 | 22.9 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.8 | 5.7 | GO:0031988 | membrane-bounded vesicle(GO:0031988) |
0.8 | 15.4 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.8 | 1.6 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.8 | 2.4 | GO:0044853 | plasma membrane raft(GO:0044853) |
0.8 | 7.1 | GO:0030425 | dendrite(GO:0030425) |
0.8 | 16.6 | GO:0045171 | intercellular bridge(GO:0045171) |
0.8 | 1.6 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.8 | 3.1 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.8 | 7.0 | GO:0055037 | recycling endosome(GO:0055037) |
0.8 | 0.8 | GO:0031261 | DNA replication preinitiation complex(GO:0031261) |
0.8 | 3.1 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.8 | 46.2 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.8 | 14.6 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.8 | 3.1 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.8 | 5.4 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.8 | 4.6 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.8 | 2.3 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.8 | 2.3 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.8 | 5.3 | GO:0000124 | SAGA complex(GO:0000124) |
0.8 | 9.9 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.8 | 3.8 | GO:0005796 | Golgi lumen(GO:0005796) |
0.8 | 0.8 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.8 | 3.8 | GO:0031082 | BLOC complex(GO:0031082) |
0.7 | 48.9 | GO:0000793 | condensed chromosome(GO:0000793) |
0.7 | 7.4 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.7 | 1.5 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.7 | 8.1 | GO:0031528 | microvillus membrane(GO:0031528) |
0.7 | 1.5 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.7 | 5.9 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.7 | 4.4 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.7 | 3.6 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.7 | 5.1 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.7 | 163.4 | GO:0005813 | centrosome(GO:0005813) |
0.7 | 4.3 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.7 | 10.1 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.7 | 1.4 | GO:0005955 | calcineurin complex(GO:0005955) |
0.7 | 12.0 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.7 | 3.5 | GO:0042588 | zymogen granule(GO:0042588) |
0.7 | 7.0 | GO:0035861 | site of double-strand break(GO:0035861) |
0.7 | 2.1 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.7 | 18.2 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.7 | 7.7 | GO:0005682 | U5 snRNP(GO:0005682) |
0.7 | 4.2 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.7 | 7.0 | GO:0097346 | INO80-type complex(GO:0097346) |
0.7 | 2.1 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.7 | 0.7 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.7 | 27.5 | GO:0005770 | late endosome(GO:0005770) |
0.7 | 2.8 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.7 | 4.1 | GO:0001650 | fibrillar center(GO:0001650) |
0.7 | 23.9 | GO:0042641 | actomyosin(GO:0042641) |
0.7 | 7.5 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.7 | 5.4 | GO:0036156 | inner dynein arm(GO:0036156) |
0.7 | 2.0 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.7 | 7.3 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.7 | 474.6 | GO:0005829 | cytosol(GO:0005829) |
0.7 | 2.6 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.7 | 4.0 | GO:0042555 | MCM complex(GO:0042555) |
0.7 | 0.7 | GO:0005915 | zonula adherens(GO:0005915) |
0.7 | 0.7 | GO:0034399 | nuclear periphery(GO:0034399) |
0.6 | 19.5 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.6 | 83.5 | GO:0005874 | microtubule(GO:0005874) |
0.6 | 16.8 | GO:0034707 | chloride channel complex(GO:0034707) |
0.6 | 9.5 | GO:0030424 | axon(GO:0030424) |
0.6 | 0.6 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.6 | 5.7 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.6 | 3.2 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.6 | 13.1 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.6 | 1.8 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.6 | 15.3 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.6 | 6.7 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
0.6 | 6.7 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.6 | 0.6 | GO:0001652 | granular component(GO:0001652) |
0.6 | 52.5 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.6 | 4.1 | GO:0000228 | nuclear chromosome(GO:0000228) |
0.6 | 4.6 | GO:1990391 | DNA repair complex(GO:1990391) |
0.6 | 0.6 | GO:0070938 | contractile ring(GO:0070938) |
0.6 | 1.7 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.6 | 5.7 | GO:0030057 | desmosome(GO:0030057) |
0.6 | 5.0 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.6 | 84.8 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.6 | 1.1 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.6 | 57.1 | GO:0005667 | transcription factor complex(GO:0005667) |
0.6 | 431.6 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.6 | 6.1 | GO:0032040 | small-subunit processome(GO:0032040) |
0.5 | 4.4 | GO:0042383 | sarcolemma(GO:0042383) |
0.5 | 1.1 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.5 | 384.7 | GO:0005654 | nucleoplasm(GO:0005654) |
0.5 | 5.9 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.5 | 2.7 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.5 | 7.5 | GO:0044452 | nucleolar part(GO:0044452) |
0.5 | 6.2 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.5 | 3.6 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.5 | 75.8 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.5 | 49.9 | GO:0005773 | vacuole(GO:0005773) |
0.5 | 7.6 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.5 | 0.5 | GO:0060170 | ciliary membrane(GO:0060170) |
0.5 | 9.2 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.5 | 2.9 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.5 | 2.4 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.5 | 1.9 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.5 | 26.9 | GO:0072562 | blood microparticle(GO:0072562) |
0.5 | 2.3 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.5 | 2.3 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.5 | 1.8 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.5 | 4.5 | GO:0032982 | myosin filament(GO:0032982) |
0.5 | 0.5 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.5 | 0.9 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.4 | 5.4 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.4 | 1.3 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.4 | 0.4 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.4 | 1.7 | GO:0016272 | prefoldin complex(GO:0016272) |
0.4 | 24.3 | GO:0005581 | collagen trimer(GO:0005581) |
0.4 | 1.3 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.4 | 0.8 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.4 | 10.7 | GO:0045095 | keratin filament(GO:0045095) |
0.4 | 0.8 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.4 | 0.4 | GO:0034709 | methylosome(GO:0034709) |
0.4 | 128.3 | GO:0005794 | Golgi apparatus(GO:0005794) |
0.4 | 3.1 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.4 | 2.2 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.4 | 0.4 | GO:1990923 | PET complex(GO:1990923) |
0.4 | 0.7 | GO:0005686 | U2 snRNP(GO:0005686) |
0.4 | 1.8 | GO:0045178 | basal part of cell(GO:0045178) |
0.4 | 3.5 | GO:0032420 | stereocilium(GO:0032420) |
0.3 | 1.4 | GO:0030027 | lamellipodium(GO:0030027) |
0.3 | 3.4 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.3 | 17.5 | GO:0030133 | transport vesicle(GO:0030133) |
0.3 | 758.8 | GO:0005737 | cytoplasm(GO:0005737) |
0.3 | 0.3 | GO:0072534 | perineuronal net(GO:0072534) |
0.3 | 29.6 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.3 | 0.6 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.3 | 1.7 | GO:0072372 | primary cilium(GO:0072372) |
0.3 | 8.4 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.3 | 0.8 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.3 | 1.3 | GO:0045177 | apical part of cell(GO:0045177) |
0.2 | 1.2 | GO:0043296 | apical junction complex(GO:0043296) |
0.2 | 1.6 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.2 | 81.4 | GO:0070062 | extracellular exosome(GO:0070062) |
0.2 | 20.0 | GO:0031981 | nuclear lumen(GO:0031981) |
0.2 | 0.2 | GO:0000346 | transcription export complex(GO:0000346) |
0.2 | 0.2 | GO:0033643 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
0.2 | 1.0 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.2 | 559.0 | GO:0016021 | integral component of membrane(GO:0016021) |
0.2 | 0.2 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.1 | 33.5 | GO:0016020 | membrane(GO:0016020) |
0.1 | 0.1 | GO:0070603 | SWI/SNF superfamily-type complex(GO:0070603) |
0.1 | 0.4 | GO:0031982 | vesicle(GO:0031982) |
0.1 | 2.0 | GO:0005882 | intermediate filament(GO:0005882) |
0.1 | 0.8 | GO:0044297 | cell body(GO:0044297) |
0.0 | 0.2 | GO:0043005 | neuron projection(GO:0043005) |
0.0 | 0.1 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.0 | 0.0 | GO:0089701 | U2AF(GO:0089701) |
0.0 | 0.0 | GO:0005819 | spindle(GO:0005819) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
13.8 | 55.3 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
13.4 | 53.7 | GO:0015232 | heme transporter activity(GO:0015232) |
12.9 | 64.6 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
11.5 | 34.4 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
10.0 | 29.9 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
9.6 | 67.5 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
9.5 | 28.4 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
9.3 | 27.9 | GO:0070644 | vitamin D response element binding(GO:0070644) |
8.4 | 33.7 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
7.9 | 31.7 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
7.7 | 23.0 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
7.5 | 15.1 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
7.5 | 22.5 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
6.9 | 20.8 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
6.6 | 13.3 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
6.5 | 6.5 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
6.5 | 25.9 | GO:0051425 | PTB domain binding(GO:0051425) |
6.4 | 19.1 | GO:0004096 | catalase activity(GO:0004096) |
6.3 | 25.4 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
6.1 | 18.4 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
6.1 | 18.2 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
6.0 | 6.0 | GO:0000009 | alpha-1,6-mannosyltransferase activity(GO:0000009) |
6.0 | 17.9 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
5.8 | 52.4 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
5.8 | 34.9 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
5.5 | 21.8 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
5.4 | 32.4 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
5.2 | 15.7 | GO:0016842 | amidine-lyase activity(GO:0016842) |
5.1 | 15.3 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
5.1 | 70.8 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
4.9 | 14.8 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
4.9 | 19.7 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
4.9 | 14.7 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
4.9 | 24.3 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
4.8 | 19.2 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
4.8 | 38.0 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
4.7 | 33.1 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
4.7 | 33.0 | GO:0016803 | ether hydrolase activity(GO:0016803) |
4.7 | 18.8 | GO:0009374 | biotin binding(GO:0009374) |
4.6 | 27.5 | GO:0008199 | ferric iron binding(GO:0008199) |
4.5 | 13.5 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
4.4 | 17.7 | GO:0030911 | TPR domain binding(GO:0030911) |
4.4 | 13.2 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
4.4 | 22.0 | GO:0004031 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
4.4 | 74.1 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
4.3 | 13.0 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
4.3 | 17.3 | GO:0000403 | Y-form DNA binding(GO:0000403) |
4.3 | 47.4 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
4.3 | 21.5 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
4.3 | 8.5 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
4.3 | 59.7 | GO:0005521 | lamin binding(GO:0005521) |
4.2 | 38.0 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
4.2 | 16.9 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
4.2 | 16.8 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
4.2 | 12.5 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
4.1 | 36.8 | GO:0016004 | phospholipase activator activity(GO:0016004) |
4.0 | 12.0 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
3.9 | 11.6 | GO:0030350 | iron-responsive element binding(GO:0030350) |
3.8 | 11.4 | GO:0019961 | interferon binding(GO:0019961) |
3.7 | 7.4 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
3.7 | 11.1 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
3.7 | 11.1 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
3.6 | 3.6 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
3.6 | 7.2 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
3.6 | 10.8 | GO:2001070 | starch binding(GO:2001070) |
3.6 | 46.8 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
3.6 | 14.3 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
3.6 | 17.9 | GO:0046790 | virion binding(GO:0046790) |
3.6 | 10.7 | GO:0004064 | arylesterase activity(GO:0004064) |
3.6 | 17.8 | GO:0070061 | fructose binding(GO:0070061) |
3.5 | 24.6 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
3.5 | 13.9 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
3.5 | 6.9 | GO:0031720 | haptoglobin binding(GO:0031720) |
3.4 | 3.4 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
3.4 | 20.5 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
3.4 | 13.4 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
3.4 | 6.7 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
3.4 | 6.7 | GO:1990715 | mRNA CDS binding(GO:1990715) |
3.3 | 46.6 | GO:0010181 | FMN binding(GO:0010181) |
3.3 | 26.6 | GO:0001164 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
3.3 | 6.6 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
3.3 | 16.5 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
3.2 | 80.5 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
3.2 | 51.1 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
3.2 | 9.6 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
3.2 | 9.5 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
3.2 | 19.0 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
3.2 | 12.6 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
3.1 | 18.8 | GO:0001727 | lipid kinase activity(GO:0001727) |
3.1 | 9.4 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
3.1 | 3.1 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
3.1 | 6.2 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
3.0 | 11.8 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
2.9 | 8.8 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
2.9 | 8.7 | GO:0005344 | oxygen transporter activity(GO:0005344) |
2.8 | 17.1 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
2.8 | 5.7 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
2.8 | 11.2 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
2.8 | 25.1 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
2.8 | 8.3 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
2.8 | 30.4 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
2.8 | 38.6 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
2.7 | 11.0 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
2.7 | 8.2 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
2.7 | 8.2 | GO:0030621 | U4 snRNA binding(GO:0030621) |
2.7 | 13.5 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
2.7 | 8.1 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
2.7 | 16.1 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
2.7 | 2.7 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
2.6 | 58.2 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
2.6 | 2.6 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
2.6 | 49.5 | GO:0001848 | complement binding(GO:0001848) |
2.6 | 13.0 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
2.6 | 15.4 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
2.5 | 17.6 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
2.5 | 7.5 | GO:0005119 | smoothened binding(GO:0005119) |
2.5 | 7.5 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
2.5 | 27.5 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
2.5 | 57.0 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
2.5 | 9.9 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
2.5 | 34.5 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
2.5 | 14.8 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
2.5 | 31.9 | GO:0016805 | dipeptidase activity(GO:0016805) |
2.5 | 2.5 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
2.4 | 14.7 | GO:0016151 | nickel cation binding(GO:0016151) |
2.4 | 26.8 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
2.4 | 51.2 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
2.4 | 14.6 | GO:0030274 | LIM domain binding(GO:0030274) |
2.4 | 14.5 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
2.4 | 14.5 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
2.4 | 11.9 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
2.4 | 7.2 | GO:0070698 | type I activin receptor binding(GO:0070698) |
2.4 | 11.9 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
2.4 | 2.4 | GO:0016436 | rRNA methyltransferase activity(GO:0008649) rRNA (uridine) methyltransferase activity(GO:0016436) |
2.4 | 4.8 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
2.4 | 52.1 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
2.4 | 21.3 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
2.4 | 9.4 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
2.4 | 2.4 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
2.4 | 9.4 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
2.3 | 4.7 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
2.3 | 11.7 | GO:0008494 | translation activator activity(GO:0008494) |
2.3 | 14.1 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
2.3 | 7.0 | GO:0019002 | GMP binding(GO:0019002) |
2.3 | 16.3 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
2.3 | 41.4 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
2.3 | 4.6 | GO:0042834 | peptidoglycan binding(GO:0042834) |
2.3 | 20.3 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
2.3 | 11.3 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
2.2 | 6.7 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
2.2 | 17.7 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
2.2 | 11.0 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
2.2 | 8.8 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
2.2 | 6.6 | GO:0001030 | RNA polymerase III regulatory region DNA binding(GO:0001016) RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
2.2 | 2.2 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
2.2 | 6.5 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
2.2 | 2.2 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
2.2 | 17.4 | GO:0017166 | vinculin binding(GO:0017166) |
2.2 | 6.5 | GO:0070628 | proteasome binding(GO:0070628) |
2.2 | 6.5 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
2.2 | 4.3 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
2.2 | 15.1 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
2.2 | 10.8 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
2.1 | 6.4 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
2.1 | 17.0 | GO:0035197 | siRNA binding(GO:0035197) |
2.1 | 6.3 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
2.1 | 8.4 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
2.1 | 50.2 | GO:0035380 | C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity(GO:0000252) mevaldate reductase activity(GO:0004495) gluconate dehydrogenase activity(GO:0008875) epoxide dehydrogenase activity(GO:0018451) 5-exo-hydroxycamphor dehydrogenase activity(GO:0018452) 2-hydroxytetrahydrofuran dehydrogenase activity(GO:0018453) acetoin dehydrogenase activity(GO:0019152) phenylcoumaran benzylic ether reductase activity(GO:0032442) D-xylose:NADP reductase activity(GO:0032866) L-arabinose:NADP reductase activity(GO:0032867) D-arabinitol dehydrogenase, D-ribulose forming (NADP+) activity(GO:0033709) (R)-(-)-1,2,3,4-tetrahydronaphthol dehydrogenase activity(GO:0034831) 3-hydroxymenthone dehydrogenase activity(GO:0034840) very long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0035380) (R)-2-hydroxyisocaproate dehydrogenase activity(GO:0043713) L-arabinose 1-dehydrogenase (NADP+) activity(GO:0044103) L-xylulose reductase (NAD+) activity(GO:0044105) 3-ketoglucose-reductase activity(GO:0048258) D-arabinitol dehydrogenase, D-xylulose forming (NADP+) activity(GO:0052677) |
2.1 | 31.4 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
2.1 | 10.4 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
2.1 | 6.2 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
2.1 | 8.3 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
2.1 | 6.2 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
2.1 | 18.5 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
2.0 | 8.2 | GO:0005047 | signal recognition particle binding(GO:0005047) |
2.0 | 28.5 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
2.0 | 8.1 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
2.0 | 2.0 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
2.0 | 18.2 | GO:0008432 | JUN kinase binding(GO:0008432) |
2.0 | 40.3 | GO:0070412 | R-SMAD binding(GO:0070412) |
2.0 | 8.0 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
2.0 | 8.0 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
2.0 | 6.0 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
2.0 | 5.9 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
2.0 | 5.9 | GO:0097016 | L27 domain binding(GO:0097016) |
2.0 | 113.5 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
2.0 | 5.9 | GO:0031014 | troponin T binding(GO:0031014) |
2.0 | 31.3 | GO:0071949 | FAD binding(GO:0071949) |
1.9 | 1.9 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
1.9 | 19.4 | GO:0070182 | DNA polymerase binding(GO:0070182) |
1.9 | 5.8 | GO:0004793 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
1.9 | 3.9 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
1.9 | 5.8 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
1.9 | 40.4 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
1.9 | 7.7 | GO:0030983 | mismatched DNA binding(GO:0030983) |
1.9 | 11.5 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
1.9 | 36.3 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
1.9 | 7.6 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
1.9 | 7.6 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
1.9 | 19.0 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
1.9 | 55.0 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
1.9 | 5.6 | GO:0030620 | U2 snRNA binding(GO:0030620) |
1.9 | 39.5 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
1.9 | 22.4 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
1.9 | 11.2 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
1.9 | 37.2 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
1.9 | 5.6 | GO:0032190 | acrosin binding(GO:0032190) |
1.8 | 9.1 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
1.8 | 52.7 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
1.8 | 3.6 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
1.8 | 3.6 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
1.8 | 27.1 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
1.8 | 5.4 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
1.8 | 9.0 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
1.8 | 5.4 | GO:0043559 | insulin binding(GO:0043559) |
1.8 | 23.0 | GO:0001671 | ATPase activator activity(GO:0001671) |
1.8 | 31.6 | GO:0004364 | glutathione transferase activity(GO:0004364) |
1.8 | 3.5 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
1.7 | 7.0 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
1.7 | 5.2 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
1.7 | 7.0 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
1.7 | 5.2 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
1.7 | 171.4 | GO:0017137 | Rab GTPase binding(GO:0017137) |
1.7 | 8.7 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
1.7 | 1.7 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
1.7 | 15.4 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
1.7 | 8.5 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
1.7 | 6.8 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
1.7 | 8.5 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
1.7 | 15.3 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
1.7 | 25.3 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
1.7 | 15.0 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
1.7 | 18.3 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
1.7 | 18.2 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
1.6 | 3.3 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
1.6 | 26.3 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
1.6 | 4.9 | GO:0008147 | structural constituent of bone(GO:0008147) |
1.6 | 21.1 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
1.6 | 3.2 | GO:0001191 | transcriptional repressor activity, RNA polymerase II transcription factor binding(GO:0001191) |
1.6 | 4.8 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
1.6 | 6.4 | GO:0002060 | purine nucleobase binding(GO:0002060) |
1.6 | 6.4 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
1.6 | 36.7 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
1.6 | 53.9 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
1.6 | 4.7 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
1.6 | 36.2 | GO:0017091 | AU-rich element binding(GO:0017091) |
1.6 | 81.3 | GO:0002039 | p53 binding(GO:0002039) |
1.6 | 42.2 | GO:0008536 | Ran GTPase binding(GO:0008536) |
1.6 | 3.1 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
1.6 | 1.6 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
1.5 | 13.9 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
1.5 | 1.5 | GO:0048495 | Roundabout binding(GO:0048495) |
1.5 | 3.0 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
1.5 | 12.1 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
1.5 | 10.5 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
1.5 | 12.0 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
1.5 | 4.5 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
1.5 | 9.0 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
1.5 | 9.0 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
1.5 | 19.4 | GO:0015248 | sterol transporter activity(GO:0015248) |
1.5 | 16.4 | GO:0017160 | Ral GTPase binding(GO:0017160) |
1.5 | 41.5 | GO:0001221 | transcription cofactor binding(GO:0001221) |
1.5 | 7.4 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
1.5 | 4.4 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
1.5 | 10.2 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
1.5 | 2.9 | GO:0030284 | estrogen receptor activity(GO:0030284) |
1.4 | 2.9 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
1.4 | 4.3 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
1.4 | 5.8 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
1.4 | 27.2 | GO:0017025 | TBP-class protein binding(GO:0017025) |
1.4 | 8.6 | GO:0019213 | deacetylase activity(GO:0019213) |
1.4 | 10.0 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
1.4 | 44.0 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
1.4 | 5.7 | GO:0004969 | histamine receptor activity(GO:0004969) |
1.4 | 4.3 | GO:0030984 | kininogen binding(GO:0030984) |
1.4 | 11.3 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
1.4 | 9.8 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
1.4 | 4.2 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
1.4 | 18.1 | GO:0015116 | sulfate transmembrane transporter activity(GO:0015116) |
1.4 | 2.8 | GO:0019789 | SUMO transferase activity(GO:0019789) |
1.4 | 1.4 | GO:0035410 | dihydrotestosterone 17-beta-dehydrogenase activity(GO:0035410) |
1.4 | 1.4 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
1.4 | 13.9 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
1.4 | 5.4 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
1.4 | 4.1 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
1.4 | 5.4 | GO:0004966 | galanin receptor activity(GO:0004966) |
1.4 | 32.4 | GO:0051059 | NF-kappaB binding(GO:0051059) |
1.3 | 9.4 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
1.3 | 5.4 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
1.3 | 5.4 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
1.3 | 41.7 | GO:0070888 | E-box binding(GO:0070888) |
1.3 | 5.4 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
1.3 | 12.1 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
1.3 | 1.3 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
1.3 | 32.1 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
1.3 | 1.3 | GO:0019862 | IgA binding(GO:0019862) |
1.3 | 13.3 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
1.3 | 2.7 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
1.3 | 1.3 | GO:0030172 | troponin C binding(GO:0030172) |
1.3 | 5.3 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
1.3 | 13.1 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
1.3 | 32.1 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
1.3 | 2.6 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
1.3 | 3.8 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
1.3 | 2.5 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
1.3 | 5.0 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
1.3 | 3.8 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
1.3 | 6.3 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
1.3 | 3.8 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
1.2 | 2.5 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
1.2 | 3.7 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
1.2 | 31.1 | GO:0017022 | myosin binding(GO:0017022) |
1.2 | 11.1 | GO:0097602 | cullin family protein binding(GO:0097602) |
1.2 | 9.9 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
1.2 | 7.4 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
1.2 | 27.1 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
1.2 | 3.7 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
1.2 | 2.5 | GO:0043422 | protein kinase B binding(GO:0043422) |
1.2 | 4.9 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
1.2 | 9.8 | GO:0048156 | tau protein binding(GO:0048156) |
1.2 | 3.7 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
1.2 | 11.0 | GO:0051400 | BH domain binding(GO:0051400) |
1.2 | 3.7 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
1.2 | 6.1 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
1.2 | 1.2 | GO:0001099 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
1.2 | 40.0 | GO:0005484 | SNAP receptor activity(GO:0005484) |
1.2 | 4.8 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
1.2 | 6.1 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
1.2 | 12.1 | GO:0004568 | chitinase activity(GO:0004568) |
1.2 | 3.6 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
1.2 | 13.2 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
1.2 | 4.8 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
1.2 | 1.2 | GO:0035514 | DNA demethylase activity(GO:0035514) |
1.2 | 10.7 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
1.2 | 11.8 | GO:0048038 | quinone binding(GO:0048038) |
1.2 | 9.5 | GO:0070034 | telomerase RNA binding(GO:0070034) |
1.2 | 3.5 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
1.2 | 5.9 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
1.2 | 10.5 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
1.2 | 16.3 | GO:0017049 | GTP-Rho binding(GO:0017049) |
1.1 | 3.4 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
1.1 | 3.4 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
1.1 | 20.3 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
1.1 | 4.5 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
1.1 | 30.4 | GO:0016860 | intramolecular oxidoreductase activity(GO:0016860) |
1.1 | 2.2 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
1.1 | 4.5 | GO:0042731 | PH domain binding(GO:0042731) |
1.1 | 5.6 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
1.1 | 24.5 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
1.1 | 3.3 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
1.1 | 43.3 | GO:0003743 | translation initiation factor activity(GO:0003743) |
1.1 | 5.5 | GO:0005499 | vitamin D binding(GO:0005499) |
1.1 | 4.4 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
1.1 | 17.7 | GO:0043531 | ADP binding(GO:0043531) |
1.1 | 59.8 | GO:0061659 | ubiquitin-like protein ligase activity(GO:0061659) |
1.1 | 8.8 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
1.1 | 2.2 | GO:0031685 | adenosine receptor binding(GO:0031685) |
1.1 | 9.9 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
1.1 | 2.2 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
1.1 | 30.7 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
1.1 | 17.5 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
1.1 | 1.1 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
1.1 | 36.0 | GO:0043022 | ribosome binding(GO:0043022) |
1.1 | 5.5 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
1.1 | 3.3 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
1.1 | 2.2 | GO:0019825 | oxygen binding(GO:0019825) |
1.1 | 10.8 | GO:0005123 | death receptor binding(GO:0005123) |
1.1 | 72.4 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
1.1 | 3.2 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
1.1 | 11.8 | GO:0043176 | amine binding(GO:0043176) |
1.1 | 15.0 | GO:0016594 | glycine binding(GO:0016594) |
1.1 | 6.4 | GO:0015288 | porin activity(GO:0015288) |
1.1 | 4.3 | GO:0019808 | polyamine binding(GO:0019808) |
1.1 | 4.3 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
1.1 | 8.5 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
1.1 | 8.5 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
1.1 | 3.2 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
1.1 | 2.1 | GO:0019215 | intermediate filament binding(GO:0019215) |
1.1 | 5.3 | GO:0070728 | leucine binding(GO:0070728) |
1.1 | 19.0 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
1.1 | 6.3 | GO:0070402 | NADPH binding(GO:0070402) |
1.0 | 11.5 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
1.0 | 6.3 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
1.0 | 4.2 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
1.0 | 3.1 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
1.0 | 15.5 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
1.0 | 6.2 | GO:0051787 | misfolded protein binding(GO:0051787) |
1.0 | 4.1 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
1.0 | 1.0 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
1.0 | 1.0 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
1.0 | 6.1 | GO:0050733 | RS domain binding(GO:0050733) |
1.0 | 10.2 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
1.0 | 2.0 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
1.0 | 5.1 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
1.0 | 4.0 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
1.0 | 3.0 | GO:0046979 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
1.0 | 10.0 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
1.0 | 8.9 | GO:0031996 | thioesterase binding(GO:0031996) |
1.0 | 14.9 | GO:0031489 | myosin V binding(GO:0031489) |
1.0 | 1.0 | GO:0000339 | RNA cap binding(GO:0000339) RNA 7-methylguanosine cap binding(GO:0000340) |
1.0 | 1.0 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
1.0 | 9.8 | GO:0015250 | water channel activity(GO:0015250) |
1.0 | 32.3 | GO:0005507 | copper ion binding(GO:0005507) |
1.0 | 4.9 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
1.0 | 6.8 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
1.0 | 1.0 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
1.0 | 5.8 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
1.0 | 11.6 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
1.0 | 4.8 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
1.0 | 82.4 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
1.0 | 5.7 | GO:0008198 | ferrous iron binding(GO:0008198) |
1.0 | 82.3 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
1.0 | 67.9 | GO:0002020 | protease binding(GO:0002020) |
1.0 | 1.9 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.9 | 13.3 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.9 | 1.9 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.9 | 1.9 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.9 | 2.8 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.9 | 0.9 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.9 | 2.8 | GO:0000182 | rDNA binding(GO:0000182) |
0.9 | 1.8 | GO:1990188 | euchromatin binding(GO:1990188) |
0.9 | 30.3 | GO:0019209 | kinase activator activity(GO:0019209) |
0.9 | 42.9 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.9 | 2.7 | GO:0038100 | nodal binding(GO:0038100) |
0.9 | 3.6 | GO:0042910 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.9 | 23.5 | GO:0031491 | nucleosome binding(GO:0031491) |
0.9 | 1.8 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.9 | 19.0 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.9 | 8.1 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.9 | 4.5 | GO:0017136 | NAD-dependent histone deacetylase activity(GO:0017136) |
0.9 | 2.7 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.9 | 174.6 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.9 | 3.6 | GO:0070403 | NAD+ binding(GO:0070403) |
0.9 | 7.1 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.9 | 4.4 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.9 | 14.2 | GO:0030506 | ankyrin binding(GO:0030506) |
0.9 | 5.3 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.9 | 1.8 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
0.9 | 2.6 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.9 | 7.0 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.9 | 4.3 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.9 | 5.1 | GO:0043733 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.9 | 1.7 | GO:0015186 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.9 | 12.8 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.9 | 1.7 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.9 | 2.6 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.8 | 1.7 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.8 | 10.9 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.8 | 7.5 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.8 | 5.0 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.8 | 29.7 | GO:0051117 | ATPase binding(GO:0051117) |
0.8 | 0.8 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.8 | 1.6 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.8 | 1.6 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.8 | 5.8 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.8 | 2.5 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.8 | 3.3 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.8 | 2.4 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.8 | 20.3 | GO:0015485 | cholesterol binding(GO:0015485) |
0.8 | 69.3 | GO:0042393 | histone binding(GO:0042393) |
0.8 | 12.8 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.8 | 2.4 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.8 | 11.2 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.8 | 0.8 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.8 | 44.4 | GO:0008565 | protein transporter activity(GO:0008565) |
0.8 | 159.3 | GO:0016879 | ligase activity, forming carbon-nitrogen bonds(GO:0016879) |
0.8 | 3.2 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.8 | 2.4 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.8 | 14.9 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.8 | 0.8 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.8 | 8.6 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.8 | 3.1 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.8 | 18.8 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.8 | 31.2 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.8 | 31.9 | GO:0001047 | core promoter binding(GO:0001047) |
0.8 | 20.0 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.8 | 13.0 | GO:0005537 | mannose binding(GO:0005537) |
0.8 | 22.1 | GO:0052770 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.8 | 8.3 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.8 | 2.3 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.8 | 21.0 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.7 | 3.0 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.7 | 2.2 | GO:0019239 | deaminase activity(GO:0019239) |
0.7 | 3.7 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.7 | 1.5 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.7 | 3.0 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.7 | 1.5 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.7 | 9.5 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.7 | 3.7 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.7 | 15.9 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.7 | 3.6 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.7 | 3.6 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.7 | 4.3 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.7 | 2.9 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.7 | 13.6 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.7 | 4.3 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.7 | 23.4 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.7 | 1.4 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.7 | 1.4 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.7 | 12.7 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.7 | 1.4 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.7 | 0.7 | GO:0043028 | cysteine-type endopeptidase regulator activity involved in apoptotic process(GO:0043028) |
0.7 | 2.8 | GO:0031005 | filamin binding(GO:0031005) |
0.7 | 4.2 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.7 | 1.4 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.7 | 2.1 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.7 | 0.7 | GO:0019187 | beta-1,4-mannosyltransferase activity(GO:0019187) |
0.7 | 2.8 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.7 | 4.1 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.7 | 4.8 | GO:0052687 | 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.7 | 4.8 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.7 | 2.1 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.7 | 1.4 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.7 | 6.1 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.7 | 2.0 | GO:0008430 | selenium binding(GO:0008430) |
0.7 | 7.5 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.7 | 4.1 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.7 | 2.7 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.7 | 30.3 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.7 | 17.5 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.7 | 0.7 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.7 | 6.7 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.7 | 0.7 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.7 | 7.4 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.7 | 17.4 | GO:0097110 | scaffold protein binding(GO:0097110) |
0.7 | 2.7 | GO:0055106 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.7 | 2.6 | GO:0031419 | cobalamin binding(GO:0031419) |
0.7 | 3.9 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.7 | 7.2 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.6 | 2.6 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.6 | 6.5 | GO:0022842 | leak channel activity(GO:0022840) potassium ion leak channel activity(GO:0022841) narrow pore channel activity(GO:0022842) |
0.6 | 1.9 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.6 | 4.5 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.6 | 1.3 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.6 | 1.9 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.6 | 2.6 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.6 | 3.2 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.6 | 0.6 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.6 | 1.9 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.6 | 3.8 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.6 | 15.2 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.6 | 8.8 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.6 | 1.9 | GO:0043199 | sulfate binding(GO:0043199) |
0.6 | 1.9 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.6 | 1.3 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.6 | 4.4 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.6 | 3.1 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.6 | 4.4 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.6 | 2.5 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.6 | 3.1 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.6 | 2.5 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.6 | 5.6 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.6 | 9.9 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.6 | 3.1 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.6 | 1.9 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.6 | 7.4 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) exoribonuclease activity, producing 5'-phosphomonoesters(GO:0016896) |
0.6 | 1.8 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) calcium:cation antiporter activity(GO:0015368) |
0.6 | 0.6 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.6 | 1.2 | GO:0048185 | activin binding(GO:0048185) |
0.6 | 0.6 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.6 | 9.2 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.6 | 1.8 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.6 | 9.2 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.6 | 1.8 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.6 | 2.4 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.6 | 6.7 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.6 | 0.6 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.6 | 0.6 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.6 | 10.8 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.6 | 1.2 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.6 | 28.6 | GO:0008186 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.6 | 4.8 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.6 | 3.0 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.6 | 6.5 | GO:0008143 | poly(A) binding(GO:0008143) |
0.6 | 0.6 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.6 | 7.0 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.6 | 15.1 | GO:0043765 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.6 | 1.7 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.6 | 2.3 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.6 | 1.7 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.6 | 2.3 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.6 | 1.1 | GO:0034618 | arginine binding(GO:0034618) |
0.6 | 11.4 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.6 | 5.7 | GO:0016667 | oxidoreductase activity, acting on a sulfur group of donors(GO:0016667) |
0.6 | 121.9 | GO:0005525 | GTP binding(GO:0005525) |
0.6 | 1.7 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.6 | 5.7 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.6 | 21.5 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.6 | 9.6 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.6 | 0.6 | GO:0032934 | sterol binding(GO:0032934) |
0.6 | 1.1 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.6 | 1.7 | GO:0071253 | connexin binding(GO:0071253) |
0.6 | 1.1 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.6 | 4.4 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.6 | 1.1 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
0.6 | 3.9 | GO:0001618 | virus receptor activity(GO:0001618) |
0.6 | 1.7 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.5 | 1.1 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.5 | 0.5 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.5 | 21.6 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.5 | 0.5 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.5 | 1.1 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.5 | 19.3 | GO:0004386 | helicase activity(GO:0004386) |
0.5 | 2.1 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.5 | 4.8 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.5 | 4.8 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.5 | 62.1 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.5 | 1.1 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.5 | 2.1 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.5 | 4.7 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.5 | 2.1 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.5 | 2.6 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.5 | 3.7 | GO:0035173 | histone kinase activity(GO:0035173) |
0.5 | 56.3 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.5 | 4.7 | GO:0003796 | lysozyme activity(GO:0003796) |
0.5 | 0.5 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.5 | 11.9 | GO:0019894 | kinesin binding(GO:0019894) |
0.5 | 21.6 | GO:0008757 | S-adenosylmethionine-dependent methyltransferase activity(GO:0008757) |
0.5 | 114.6 | GO:0046982 | protein heterodimerization activity(GO:0046982) |
0.5 | 36.4 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.5 | 3.6 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.5 | 1.5 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.5 | 3.6 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.5 | 275.8 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.5 | 5.5 | GO:0004175 | endopeptidase activity(GO:0004175) |
0.5 | 1.0 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.5 | 3.4 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.5 | 2.9 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.5 | 1.0 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.5 | 2.4 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.5 | 1.9 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.5 | 21.3 | GO:0046906 | tetrapyrrole binding(GO:0046906) |
0.5 | 8.0 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.5 | 0.5 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) |
0.5 | 2.3 | GO:0043274 | phospholipase binding(GO:0043274) |
0.5 | 1.9 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.5 | 1.4 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.5 | 39.3 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.5 | 0.5 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.5 | 0.9 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.5 | 1.8 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.5 | 2.3 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.5 | 13.5 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.5 | 0.9 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.4 | 6.3 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.4 | 1.3 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.4 | 0.9 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.4 | 5.8 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.4 | 1.3 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.4 | 8.4 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
0.4 | 68.9 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.4 | 12.2 | GO:0051723 | protein methylesterase activity(GO:0051723) |
0.4 | 2.6 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.4 | 2.2 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.4 | 4.7 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.4 | 4.2 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.4 | 0.8 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.4 | 0.4 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.4 | 6.3 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.4 | 13.1 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.4 | 4.6 | GO:1990939 | ATP-dependent microtubule motor activity(GO:1990939) |
0.4 | 0.8 | GO:0035473 | lipase binding(GO:0035473) |
0.4 | 0.8 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.4 | 0.4 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.4 | 1.2 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.4 | 6.8 | GO:0016414 | O-octanoyltransferase activity(GO:0016414) |
0.4 | 0.4 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.4 | 1.6 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.4 | 0.4 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.4 | 3.5 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.4 | 0.8 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.4 | 1.2 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.4 | 2.0 | GO:0016454 | C-palmitoyltransferase activity(GO:0016454) |
0.4 | 0.8 | GO:0016631 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.4 | 1.9 | GO:0042300 | pseudouridine synthase activity(GO:0009982) pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.4 | 0.4 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.4 | 1.2 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.4 | 21.3 | GO:0019902 | phosphatase binding(GO:0019902) |
0.4 | 0.4 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.4 | 4.2 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.4 | 6.1 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.4 | 1.1 | GO:0043515 | kinetochore binding(GO:0043515) |
0.4 | 22.1 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.4 | 2.3 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.4 | 1.5 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.4 | 0.4 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.4 | 1.1 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.4 | 6.0 | GO:0051087 | chaperone binding(GO:0051087) |
0.4 | 4.1 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.4 | 49.3 | GO:0019900 | kinase binding(GO:0019900) |
0.4 | 5.9 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.4 | 0.4 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.4 | 1.1 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.4 | 1.1 | GO:0005048 | signal sequence binding(GO:0005048) |
0.4 | 5.7 | GO:0052693 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) epoxyqueuosine reductase activity(GO:0052693) |
0.4 | 0.7 | GO:0015923 | mannosidase activity(GO:0015923) |
0.4 | 1.4 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.4 | 1.8 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.4 | 15.9 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.4 | 0.4 | GO:0030371 | translation repressor activity(GO:0030371) |
0.3 | 0.7 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.3 | 2.7 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.3 | 0.7 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.3 | 0.7 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.3 | 11.1 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.3 | 0.7 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.3 | 1.6 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.3 | 9.5 | GO:0004553 | hydrolase activity, hydrolyzing O-glycosyl compounds(GO:0004553) |
0.3 | 0.3 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.3 | 1.2 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.3 | 0.9 | GO:0030515 | snoRNA binding(GO:0030515) |
0.3 | 0.3 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.3 | 61.7 | GO:0005198 | structural molecule activity(GO:0005198) |
0.3 | 0.6 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.3 | 2.7 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.3 | 6.0 | GO:0050699 | WW domain binding(GO:0050699) |
0.3 | 2.1 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.3 | 2.1 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.3 | 0.3 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.3 | 5.9 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.3 | 1.1 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.3 | 0.8 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.3 | 3.8 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
0.3 | 12.1 | GO:0000149 | SNARE binding(GO:0000149) |
0.3 | 0.3 | GO:0060229 | lipase activator activity(GO:0060229) |
0.3 | 6.3 | GO:0016409 | palmitoyltransferase activity(GO:0016409) |
0.3 | 27.0 | GO:0003682 | chromatin binding(GO:0003682) |
0.3 | 0.3 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
0.3 | 0.5 | GO:0016801 | hydrolase activity, acting on ether bonds(GO:0016801) |
0.3 | 1.3 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.2 | 0.2 | GO:0019887 | protein kinase regulator activity(GO:0019887) |
0.2 | 4.5 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.2 | 0.5 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.2 | 19.7 | GO:0016887 | ATPase activity(GO:0016887) |
0.2 | 1.0 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.2 | 0.7 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.2 | 10.0 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.2 | 0.5 | GO:0034452 | dynactin binding(GO:0034452) |
0.2 | 4.6 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.2 | 1.2 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.2 | 2.4 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.2 | 0.2 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.2 | 0.9 | GO:0015643 | toxic substance binding(GO:0015643) |
0.2 | 0.5 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.2 | 0.9 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.2 | 2.2 | GO:0043734 | DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.2 | 5.3 | GO:0005496 | steroid binding(GO:0005496) |
0.2 | 1.3 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.2 | 2.2 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.2 | 1.1 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.2 | 0.2 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.2 | 0.4 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.2 | 0.2 | GO:0051536 | iron-sulfur cluster binding(GO:0051536) metal cluster binding(GO:0051540) |
0.2 | 0.2 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.2 | 0.4 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.2 | 22.1 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.2 | 0.6 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.2 | 2.0 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.2 | 0.6 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.2 | 0.8 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.2 | 0.4 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.2 | 6.0 | GO:0044212 | transcription regulatory region DNA binding(GO:0044212) |
0.2 | 8.1 | GO:0004518 | nuclease activity(GO:0004518) |
0.2 | 0.6 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.2 | 1.5 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.2 | 0.4 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.2 | 0.2 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.2 | 0.7 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.2 | 17.6 | GO:0003690 | double-stranded DNA binding(GO:0003690) |
0.2 | 17.2 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
0.2 | 1.4 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.2 | 2.3 | GO:0016874 | ligase activity(GO:0016874) |
0.2 | 0.7 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.2 | 0.3 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.2 | 3.5 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.2 | 3.8 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.2 | 0.2 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.2 | 0.5 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.2 | 1.8 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.2 | 0.3 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.2 | 0.8 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.2 | 1.4 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.2 | 0.8 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.1 | 0.1 | GO:0034212 | peptide N-acetyltransferase activity(GO:0034212) |
0.1 | 6.1 | GO:0003712 | transcription cofactor activity(GO:0003712) |
0.1 | 0.4 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.1 | 0.3 | GO:0033612 | receptor serine/threonine kinase binding(GO:0033612) |
0.1 | 161.1 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.1 | 0.6 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 0.7 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
0.1 | 0.8 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.1 | 0.4 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.1 | 0.1 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.1 | 2.4 | GO:0008233 | peptidase activity(GO:0008233) |
0.1 | 6.2 | GO:0051015 | actin filament binding(GO:0051015) |
0.1 | 39.2 | GO:0008270 | zinc ion binding(GO:0008270) |
0.1 | 0.5 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 1.2 | GO:0043621 | protein self-association(GO:0043621) |
0.1 | 2.0 | GO:0003823 | antigen binding(GO:0003823) |
0.1 | 0.3 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 0.3 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 0.6 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 4.9 | GO:0031625 | ubiquitin protein ligase binding(GO:0031625) |
0.1 | 2.1 | GO:0005186 | pheromone activity(GO:0005186) |
0.1 | 35.0 | GO:0003700 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.1 | 2.1 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 0.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.1 | 0.1 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.1 | 0.2 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.1 | 0.2 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 0.3 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.1 | 0.4 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.1 | 3.2 | GO:0015085 | calcium ion transmembrane transporter activity(GO:0015085) |
0.1 | 0.1 | GO:0008061 | chitin binding(GO:0008061) |
0.1 | 0.5 | GO:0005504 | fatty acid binding(GO:0005504) |
0.1 | 0.1 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.1 | 9.0 | GO:0005550 | pheromone binding(GO:0005550) |
0.1 | 0.1 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.1 | 0.4 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.1 | 2.0 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.1 | 0.3 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.1 | 2.0 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
0.1 | 5.8 | GO:0008134 | transcription factor binding(GO:0008134) |
0.1 | 0.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.3 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.1 | 3.7 | GO:0008527 | taste receptor activity(GO:0008527) |
0.1 | 0.5 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 0.7 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) intracellular cAMP activated cation channel activity(GO:0005222) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.1 | 0.8 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.1 | 0.2 | GO:0016307 | phosphatidylinositol phosphate kinase activity(GO:0016307) |
0.1 | 0.1 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.1 | 0.1 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 0.1 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 0.2 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.1 | 7.7 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.1 | 0.2 | GO:0016706 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors(GO:0016706) |
0.1 | 0.2 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.1 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 0.1 | GO:0061135 | endopeptidase regulator activity(GO:0061135) |
0.1 | 0.1 | GO:0051379 | epinephrine binding(GO:0051379) |
0.1 | 2.8 | GO:0035091 | phosphatidylinositol binding(GO:0035091) |
0.1 | 0.1 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.1 | 0.1 | GO:1990446 | snRNP binding(GO:0070990) U1 snRNP binding(GO:1990446) |
0.1 | 0.1 | GO:0032182 | ubiquitin-like protein binding(GO:0032182) |
0.1 | 3.3 | GO:0004857 | enzyme inhibitor activity(GO:0004857) |
0.1 | 0.4 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.1 | 0.1 | GO:0015298 | solute:cation antiporter activity(GO:0015298) |
0.1 | 0.3 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.0 | 0.2 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.7 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.0 | 0.0 | GO:0051373 | FATZ binding(GO:0051373) |
0.0 | 0.4 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 0.0 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.0 | 3.7 | GO:0003779 | actin binding(GO:0003779) |
0.0 | 0.2 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.1 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.0 | 0.3 | GO:0015932 | nucleobase-containing compound transmembrane transporter activity(GO:0015932) |
0.0 | 1.6 | GO:0016757 | transferase activity, transferring glycosyl groups(GO:0016757) |
0.0 | 0.2 | GO:0031386 | protein tag(GO:0031386) |
0.0 | 0.0 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.0 | 0.1 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.0 | GO:0016798 | hydrolase activity, acting on glycosyl bonds(GO:0016798) |
0.0 | 0.0 | GO:0009055 | electron carrier activity(GO:0009055) |
0.0 | 0.0 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.0 | 0.2 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 11.7 | GO:0046872 | metal ion binding(GO:0046872) |
0.0 | 0.0 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.0 | 0.1 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.0 | 0.0 | GO:0033265 | choline binding(GO:0033265) |
0.0 | 0.1 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 0.0 | GO:0016725 | oxidoreductase activity, acting on CH or CH2 groups(GO:0016725) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.2 | 108.0 | ST GAQ PATHWAY | G alpha q Pathway |
3.4 | 61.6 | PID ARF 3PATHWAY | Arf1 pathway |
3.3 | 85.6 | PID IL3 PATHWAY | IL3-mediated signaling events |
3.3 | 3.3 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
3.0 | 33.2 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
2.8 | 48.4 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
2.8 | 126.1 | PID FOXO PATHWAY | FoxO family signaling |
2.7 | 54.5 | PID IGF1 PATHWAY | IGF1 pathway |
2.7 | 24.3 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
2.4 | 31.2 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
2.4 | 42.9 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
2.4 | 16.7 | PID S1P S1P1 PATHWAY | S1P1 pathway |
2.2 | 49.0 | PID TNF PATHWAY | TNF receptor signaling pathway |
2.2 | 13.3 | PID ERBB4 PATHWAY | ErbB4 signaling events |
2.2 | 8.8 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
2.1 | 20.8 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
2.0 | 18.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
2.0 | 16.1 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
2.0 | 41.6 | PID CONE PATHWAY | Visual signal transduction: Cones |
2.0 | 25.4 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
2.0 | 101.4 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
1.9 | 21.3 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
1.9 | 25.2 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
1.9 | 21.2 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
1.9 | 89.3 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
1.9 | 54.2 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
1.8 | 27.4 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
1.7 | 157.9 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
1.6 | 32.5 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
1.6 | 32.6 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
1.5 | 41.8 | PID P53 REGULATION PATHWAY | p53 pathway |
1.5 | 50.4 | PID ILK PATHWAY | Integrin-linked kinase signaling |
1.5 | 7.6 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
1.4 | 59.8 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
1.4 | 24.1 | PID RHOA PATHWAY | RhoA signaling pathway |
1.4 | 5.6 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
1.4 | 4.2 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
1.4 | 36.1 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
1.4 | 16.6 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
1.4 | 46.9 | PID AP1 PATHWAY | AP-1 transcription factor network |
1.4 | 15.1 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
1.4 | 48.7 | PID CDC42 PATHWAY | CDC42 signaling events |
1.3 | 10.7 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
1.3 | 9.3 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
1.3 | 14.5 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
1.3 | 39.5 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
1.3 | 10.4 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
1.3 | 16.9 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
1.3 | 9.1 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
1.3 | 6.4 | PID MYC PATHWAY | C-MYC pathway |
1.3 | 5.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
1.2 | 24.7 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
1.2 | 16.0 | PID AURORA A PATHWAY | Aurora A signaling |
1.2 | 52.2 | PID CMYB PATHWAY | C-MYB transcription factor network |
1.2 | 2.4 | PID S1P S1P2 PATHWAY | S1P2 pathway |
1.2 | 1.2 | ST STAT3 PATHWAY | STAT3 Pathway |
1.2 | 16.3 | PID IL1 PATHWAY | IL1-mediated signaling events |
1.1 | 11.0 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
1.1 | 20.9 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
1.1 | 2.2 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
1.1 | 23.5 | PID MTOR 4PATHWAY | mTOR signaling pathway |
1.1 | 1.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
1.0 | 4.2 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
1.0 | 2.1 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
1.0 | 1.0 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
1.0 | 14.8 | PID ARF6 PATHWAY | Arf6 signaling events |
1.0 | 7.9 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
1.0 | 26.6 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
1.0 | 4.8 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
1.0 | 35.4 | PID NOTCH PATHWAY | Notch signaling pathway |
0.9 | 23.7 | PID AURORA B PATHWAY | Aurora B signaling |
0.9 | 1.9 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.9 | 9.0 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.9 | 2.6 | PID IFNG PATHWAY | IFN-gamma pathway |
0.8 | 0.8 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.8 | 7.6 | PID ALK2 PATHWAY | ALK2 signaling events |
0.8 | 4.2 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.8 | 16.7 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.8 | 6.7 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.8 | 4.1 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.8 | 1.6 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.8 | 1.6 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.8 | 4.6 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.8 | 15.1 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.7 | 8.9 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.7 | 26.7 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.7 | 0.7 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.7 | 5.6 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.7 | 7.6 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.7 | 2.1 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.7 | 3.4 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.7 | 10.2 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.7 | 12.8 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.7 | 6.6 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.6 | 8.5 | PID BARD1 PATHWAY | BARD1 signaling events |
0.6 | 1.1 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.6 | 4.4 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.5 | 1.6 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.5 | 11.7 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.5 | 0.5 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.5 | 0.5 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.5 | 11.6 | PID PLK1 PATHWAY | PLK1 signaling events |
0.5 | 5.4 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.5 | 1.9 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.5 | 4.3 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.5 | 1.9 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.5 | 8.7 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.5 | 11.8 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.5 | 5.0 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.4 | 4.5 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.4 | 5.1 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.4 | 7.6 | PID P73PATHWAY | p73 transcription factor network |
0.4 | 11.4 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.4 | 5.1 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.4 | 5.2 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.4 | 4.1 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.4 | 4.0 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.3 | 6.4 | PID BCR 5PATHWAY | BCR signaling pathway |
0.3 | 5.3 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.3 | 39.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.3 | 4.2 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.3 | 0.6 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.3 | 0.3 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.3 | 0.6 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.3 | 4.5 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.3 | 2.0 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.3 | 2.2 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.2 | 3.4 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.2 | 0.5 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.2 | 2.6 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.2 | 0.2 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.2 | 2.1 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.2 | 0.4 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.2 | 2.5 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.2 | 5.3 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.2 | 1.8 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.2 | 29.9 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.2 | 0.4 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.2 | 6.5 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.2 | 1.0 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.2 | 0.3 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.2 | 0.3 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.2 | 0.3 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.2 | 1.2 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 3.0 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 4.7 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 1.2 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 2.7 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 0.3 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 0.1 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 0.1 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 0.7 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 0.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 0.4 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 0.2 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 7.2 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 3.3 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.8 | 74.7 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
5.9 | 58.8 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
5.7 | 91.6 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
5.6 | 5.6 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
5.3 | 47.4 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
5.2 | 26.2 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
4.8 | 47.5 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
4.6 | 54.8 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
4.4 | 35.3 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
4.4 | 96.1 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
4.3 | 47.7 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
4.1 | 37.3 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
3.7 | 37.4 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
3.6 | 3.6 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
3.4 | 34.1 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
3.3 | 45.8 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
3.2 | 158.3 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
3.1 | 65.9 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
3.1 | 46.2 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
3.0 | 30.1 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
2.9 | 35.2 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
2.9 | 139.6 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
2.8 | 28.2 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
2.8 | 25.1 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
2.7 | 34.9 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
2.6 | 45.0 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
2.5 | 25.3 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
2.5 | 67.2 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
2.5 | 37.3 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
2.5 | 29.8 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
2.5 | 19.7 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
2.4 | 58.6 | REACTOME G1 PHASE | Genes involved in G1 Phase |
2.4 | 36.5 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
2.4 | 31.6 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
2.4 | 2.4 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
2.4 | 23.7 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
2.3 | 49.2 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
2.3 | 25.5 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
2.3 | 60.2 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
2.3 | 20.6 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
2.2 | 22.4 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
2.2 | 64.4 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
2.2 | 35.2 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
2.2 | 6.6 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
2.1 | 23.5 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
2.1 | 63.9 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
2.1 | 14.4 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
2.0 | 18.3 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
2.0 | 24.2 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
1.9 | 21.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
1.9 | 11.3 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
1.9 | 81.5 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
1.8 | 33.2 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
1.8 | 41.6 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
1.8 | 1.8 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
1.7 | 48.4 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
1.6 | 147.5 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
1.6 | 11.2 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
1.6 | 33.3 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
1.6 | 1.6 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
1.5 | 1.5 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
1.5 | 30.6 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
1.5 | 6.1 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
1.5 | 33.4 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
1.5 | 45.4 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
1.4 | 18.6 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
1.4 | 21.1 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
1.4 | 25.2 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
1.4 | 1.4 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
1.4 | 23.5 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
1.4 | 12.5 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
1.3 | 4.0 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
1.3 | 9.2 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
1.3 | 3.9 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
1.3 | 15.7 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
1.3 | 15.6 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
1.3 | 5.2 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
1.3 | 16.7 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
1.3 | 28.2 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
1.3 | 34.0 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
1.2 | 1.2 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
1.2 | 18.4 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
1.2 | 6.1 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
1.2 | 41.9 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
1.2 | 23.8 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
1.2 | 4.8 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
1.2 | 30.6 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
1.2 | 14.1 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
1.2 | 7.0 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
1.2 | 3.5 | REACTOME MITOTIC G2 G2 M PHASES | Genes involved in Mitotic G2-G2/M phases |
1.2 | 40.6 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
1.2 | 20.7 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
1.1 | 5.7 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
1.1 | 5.7 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
1.1 | 46.8 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
1.1 | 24.8 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
1.1 | 57.3 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
1.1 | 3.3 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
1.1 | 26.4 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
1.1 | 7.6 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
1.1 | 19.4 | REACTOME REGULATION OF MITOTIC CELL CYCLE | Genes involved in Regulation of mitotic cell cycle |
1.1 | 9.6 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
1.1 | 1.1 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
1.1 | 14.7 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
1.0 | 33.4 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
1.0 | 2.1 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
1.0 | 59.4 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
1.0 | 27.0 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
1.0 | 15.0 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
1.0 | 32.8 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
1.0 | 1.0 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
1.0 | 2.9 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
1.0 | 5.7 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.9 | 9.5 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.9 | 9.3 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.9 | 45.4 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.9 | 19.4 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.9 | 10.0 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.9 | 6.3 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.9 | 9.8 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.9 | 0.9 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.9 | 51.6 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.9 | 2.7 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.9 | 8.8 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.9 | 7.9 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.9 | 3.5 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.9 | 11.2 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.9 | 9.4 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.8 | 5.9 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.8 | 37.3 | REACTOME RNA POL II TRANSCRIPTION | Genes involved in RNA Polymerase II Transcription |
0.8 | 4.1 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.8 | 9.0 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.8 | 13.0 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.8 | 28.2 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.8 | 28.9 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.8 | 7.9 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.8 | 15.7 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.8 | 90.5 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.8 | 0.8 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.8 | 5.4 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.8 | 16.7 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.8 | 5.3 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.7 | 76.3 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.7 | 1.5 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.7 | 8.1 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.7 | 6.5 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.7 | 2.2 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.7 | 30.6 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.7 | 6.4 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.7 | 43.1 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.7 | 4.2 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.7 | 2.1 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.7 | 2.0 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.7 | 6.7 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.7 | 8.1 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.6 | 5.8 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.6 | 1.3 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.6 | 8.4 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
0.6 | 3.8 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.6 | 1.2 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.6 | 1.2 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.6 | 3.6 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.6 | 3.6 | REACTOME TRANSCRIPTION COUPLED NER TC NER | Genes involved in Transcription-coupled NER (TC-NER) |
0.6 | 1.1 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.6 | 3.9 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.6 | 3.3 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.6 | 6.1 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
0.6 | 5.0 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.5 | 2.2 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.5 | 22.8 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.5 | 12.3 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.5 | 2.1 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.5 | 4.6 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.5 | 33.9 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.5 | 9.6 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.5 | 2.5 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.5 | 4.9 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.5 | 0.5 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.5 | 13.6 | REACTOME TRANSLATION | Genes involved in Translation |
0.5 | 3.8 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.5 | 10.8 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.5 | 19.4 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.5 | 17.2 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.4 | 27.6 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.4 | 3.9 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.4 | 4.1 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.4 | 11.7 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.4 | 0.4 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.4 | 9.2 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.4 | 5.5 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.4 | 9.3 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.4 | 1.9 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.4 | 1.2 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.4 | 41.0 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.4 | 3.3 | REACTOME METABOLISM OF RNA | Genes involved in Metabolism of RNA |
0.4 | 3.0 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.4 | 12.5 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.4 | 1.1 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.3 | 2.8 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.3 | 6.7 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.3 | 5.3 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.3 | 0.3 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.3 | 5.5 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.3 | 1.6 | REACTOME TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT | Genes involved in The citric acid (TCA) cycle and respiratory electron transport |
0.3 | 0.9 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.3 | 1.9 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.3 | 1.5 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.3 | 1.2 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.3 | 3.5 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.3 | 0.3 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.3 | 1.4 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.3 | 2.9 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.3 | 0.8 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.2 | 0.7 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.2 | 1.5 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.2 | 14.4 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.2 | 3.7 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.2 | 3.3 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.2 | 0.4 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.2 | 3.0 | REACTOME DNA REPLICATION | Genes involved in DNA Replication |
0.2 | 2.0 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.2 | 1.4 | REACTOME CD28 CO STIMULATION | Genes involved in CD28 co-stimulation |
0.2 | 0.5 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.2 | 1.0 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.2 | 0.2 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.2 | 0.7 | REACTOME CELL CYCLE CHECKPOINTS | Genes involved in Cell Cycle Checkpoints |
0.2 | 0.2 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.2 | 6.7 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.2 | 0.3 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.2 | 2.0 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 0.7 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 0.7 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 0.6 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.1 | 1.8 | REACTOME TRANSPORT OF GLUCOSE AND OTHER SUGARS BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | Genes involved in Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds |
0.1 | 1.0 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.1 | 3.4 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 0.5 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.1 | 3.7 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 0.1 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.1 | 2.8 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.1 | 0.4 | REACTOME DEFENSINS | Genes involved in Defensins |
0.1 | 0.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.1 | 0.9 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 1.1 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.1 | 0.8 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 0.9 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 0.3 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 0.2 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.0 | 0.1 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.0 | 0.0 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.0 | 0.0 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |